[10-Q] American Public Education, Inc. Quarterly Earnings Report
Filing Impact
Filing Sentiment
Form Type
10-Q
Rhea-AI Filing Summary
APEI’s Q2-25 10-Q shows solid top-line growth and a sharp earnings rebound. Revenue rose 6.5% YoY to $162.8 m, driven by 7.2% growth at Rasmussen University and 6.1% at APUS, while Hondros grew 10.5%. Cost discipline limited total expense growth to 3.4%, lifting operating income to $7.0 m versus $2.2 m a year ago.
Net income surged to $4.5 m (vs. $0.4 m), but a $3.5 m loss on the June redemption of all preferred shares and $1.3 m dividends produced a $0.3 m net loss available to common holders (-$0.02 EPS). For the six-month period, diluted EPS swung to +$0.39 from -$0.12 as net income jumped to $13.4 m.
Balance sheet/liquidity: Cash climbed to $176.6 m (up $17.6 m YTD) after $51.8 m operating cash flow and $23 m of West Virginia real-estate sales. The $39.7 m preferred redemption and $43.1 m related cash outflow were funded without new debt; term-loan principal remains $96.4 m (9.9% SOFR+550 bp). Net leverage was comfortably within the 2.0× covenant.
Segment trends: APUS delivered $21.4 m operating profit (+17%), offsetting narrower operating losses at RU (-$2.0 m) and HCN (-$0.4 m). Corporate/Other posted a $12.0 m loss, reflecting GSUSA activity and unallocated costs. A definitive agreement to sell GSUSA closed on 25 Jul 25 (post-period).
Key takeaways: Earnings momentum, removal of preferred dividends, stronger cash generation, and pending GSUSA divestiture improve financial flexibility, though nursing-segment losses and higher interest expense remain watch points.
Il 10-Q di APEI per il Q2-25 mostra una solida crescita dei ricavi e un netto recupero degli utili. I ricavi sono aumentati del 6,5% su base annua, raggiungendo 162,8 milioni di dollari, grazie a una crescita del 7,2% all'Università Rasmussen e del 6,1% ad APUS, mentre Hondros ha registrato un incremento del 10,5%. La disciplina nei costi ha limitato la crescita delle spese totali al 3,4%, portando il reddito operativo a 7,0 milioni di dollari rispetto ai 2,2 milioni dell'anno precedente.
L'utile netto è salito a 4,5 milioni di dollari (contro 0,4 milioni), ma una perdita di 3,5 milioni legata al rimborso di tutte le azioni privilegiate a giugno e dividendi per 1,3 milioni hanno prodotto una perdita netta di 0,3 milioni disponibile per gli azionisti ordinari (-0,02 dollari per azione). Nel semestre, l'utile per azione diluito è passato da -0,12 a +0,39 dollari, grazie a un aumento dell'utile netto a 13,4 milioni.
Bilancio/liquidità: La liquidità è salita a 176,6 milioni di dollari (in aumento di 17,6 milioni da inizio anno) dopo un flusso di cassa operativo di 51,8 milioni e vendite immobiliari in West Virginia per 23 milioni. Il rimborso di azioni privilegiate per 39,7 milioni e il relativo esborso in contanti di 43,1 milioni sono stati finanziati senza nuovo debito; il capitale residuo del prestito a termine è di 96,4 milioni (9,9% SOFR + 550 punti base). La leva finanziaria netta resta comodamente entro il covenant di 2,0×.
Tendenze dei segmenti: APUS ha generato un utile operativo di 21,4 milioni (+17%), compensando le perdite operative più contenute di RU (-2,0 milioni) e HCN (-0,4 milioni). Corporate/Altro ha registrato una perdita di 12,0 milioni, riflettendo l'attività di GSUSA e costi non allocati. Un accordo definitivo per la vendita di GSUSA è stato chiuso il 25 luglio 2025 (dopo il periodo).
Punti chiave: L'impulso degli utili, la rimozione dei dividendi privilegiati, una generazione di cassa più solida e la prossima cessione di GSUSA migliorano la flessibilità finanziaria, anche se le perdite nel segmento infermieristico e l'aumento degli oneri finanziari restano aspetti da monitorare.
El 10-Q del segundo trimestre de 2025 de APEI muestra un sólido crecimiento en ingresos y una fuerte recuperación de ganancias. Los ingresos aumentaron un 6,5% interanual hasta 162,8 millones de dólares, impulsados por un crecimiento del 7,2% en Rasmussen University y del 6,1% en APUS, mientras que Hondros creció un 10,5%. La disciplina en los costos limitó el crecimiento total de gastos al 3,4%, elevando el ingreso operativo a 7,0 millones frente a 2,2 millones del año anterior.
El ingreso neto se disparó a 4,5 millones (vs. 0,4 millones), pero una pérdida de 3,5 millones por el rescate en junio de todas las acciones preferentes y 1,3 millones en dividendos generaron una pérdida neta de 0,3 millones disponible para los accionistas comunes (-0,02 EPS). En el período de seis meses, el EPS diluido pasó de -0,12 a +0,39, ya que el ingreso neto aumentó a 13,4 millones.
Balance/liquidez: El efectivo subió a 176,6 millones (un aumento de 17,6 millones en el año) tras un flujo de caja operativo de 51,8 millones y ventas inmobiliarias en Virginia Occidental por 23 millones. El rescate de acciones preferentes de 39,7 millones y la salida de efectivo relacionada de 43,1 millones se financiaron sin nueva deuda; el principal del préstamo a plazo sigue en 96,4 millones (9,9% SOFR + 550 pb). El apalancamiento neto se mantiene cómodamente dentro del convenio de 2,0×.
Tendencias por segmento: APUS generó una ganancia operativa de 21,4 millones (+17%), compensando las menores pérdidas operativas en RU (-2,0 millones) y HCN (-0,4 millones). Corporate/Otros registró una pérdida de 12,0 millones, reflejando la actividad de GSUSA y costos no asignados. Se cerró un acuerdo definitivo para vender GSUSA el 25 de julio de 2025 (posterior al período).
Conclusiones clave: El impulso en ganancias, la eliminación de dividendos preferentes, una generación de efectivo más fuerte y la próxima desinversión de GSUSA mejoran la flexibilidad financiera, aunque las pérdidas en el segmento de enfermería y el aumento de gastos por intereses siguen siendo puntos a vigilar.
APEI의 2025년 2분기 10-Q 보고서는 견고한 매출 성장과 급격한 수익 반등을 보여줍니다. 매출은 전년 대비 6.5% 증가한 1억 6,280만 달러로, Rasmussen University는 7.2%, APUS는 6.1%, Hondros는 10.5% 성장했습니다. 비용 관리로 총 비용 증가율은 3.4%에 그쳐 영업이익은 700만 달러로 전년 220만 달러에서 크게 상승했습니다.
순이익은 450만 달러로 급증했으나(전년 40만 달러), 6월에 모든 우선주 상환으로 인한 350만 달러 손실과 130만 달러 배당금으로 인해 보통주주에게 귀속되는 순손실 30만 달러(-주당순손실 0.02달러)가 발생했습니다. 6개월 기간 동안 희석 주당순이익은 -0.12달러에서 +0.39달러로 전환되었으며, 순이익은 1,340만 달러로 증가했습니다.
재무상태/유동성: 현금은 1억 7,660만 달러로(연초 대비 1,760만 달러 증가), 영업현금흐름 5,180만 달러와 웨스트버지니아 부동산 매각 2,300만 달러 덕분입니다. 3,970만 달러 우선주 상환과 관련 현금 유출 4,310만 달러는 신규 부채 없이 조달되었으며, 장기 대출 원금은 9,640만 달러(9.9% SOFR+550bp)로 유지되고 있습니다. 순 레버리지는 2.0배 계약 조건 내에서 안정적입니다.
사업부 동향: APUS는 2,140만 달러 영업이익(+17%)을 기록해 RU(-200만 달러)와 HCN(-40만 달러)의 영업손실 축소를 상쇄했습니다. Corporate/기타 부문은 GSUSA 활동 및 미배분 비용으로 1,200만 달러 손실을 냈습니다. GSUSA 매각에 대한 확정 계약은 2025년 7월 25일에 체결되었습니다(분기 이후).
주요 시사점: 수익 모멘텀, 우선주 배당 중단, 강한 현금 창출 및 예정된 GSUSA 매각은 재무 유연성을 개선하지만, 간호 부문의 손실과 이자 비용 증가는 계속 주시해야 할 사항입니다.
Le rapport 10-Q du deuxième trimestre 2025 d’APEI montre une croissance solide du chiffre d’affaires et un net rebond des bénéfices. Le chiffre d’affaires a augmenté de 6,5 % en glissement annuel pour atteindre 162,8 millions de dollars, porté par une croissance de 7,2 % à l’Université Rasmussen et de 6,1 % chez APUS, tandis que Hondros a progressé de 10,5 %. La discipline des coûts a limité la croissance des dépenses totales à 3,4 %, faisant passer le résultat opérationnel à 7,0 millions de dollars contre 2,2 millions l’année précédente.
Le résultat net a bondi à 4,5 millions de dollars (contre 0,4 million), mais une perte de 3,5 millions liée au rachat en juin de toutes les actions privilégiées et des dividendes de 1,3 million ont produit une perte nette de 0,3 million disponible pour les actionnaires ordinaires (-0,02 $ par action). Sur six mois, le BPA dilué est passé de -0,12 à +0,39 $ grâce à une hausse du résultat net à 13,4 millions.
Bilan/liquidité : La trésorerie a grimpé à 176,6 millions de dollars (en hausse de 17,6 millions depuis le début de l’année) après un flux de trésorerie opérationnel de 51,8 millions et des ventes immobilières en Virginie-Occidentale pour 23 millions. Le rachat des actions privilégiées de 39,7 millions et la sortie de trésorerie associée de 43,1 millions ont été financés sans nouvelle dette ; le principal du prêt à terme reste à 96,4 millions (9,9 % SOFR + 550 points de base). L’effet de levier net reste confortablement en dessous du covenant de 2,0×.
Tendances par segment : APUS a généré un résultat opérationnel de 21,4 millions (+17 %), compensant les pertes opérationnelles réduites de RU (-2,0 millions) et HCN (-0,4 million). Corporate/Autres a enregistré une perte de 12,0 millions, reflétant l’activité de GSUSA et des coûts non alloués. Un accord définitif pour la vente de GSUSA a été conclu le 25 juillet 2025 (après la période).
Points clés : La dynamique des bénéfices, la suppression des dividendes privilégiés, une génération de trésorerie plus forte et la cession imminente de GSUSA améliorent la flexibilité financière, bien que les pertes dans le segment des soins infirmiers et la hausse des charges d’intérêts restent des points à surveiller.
APEI’s 10-Q für Q2-25 zeigt solides Umsatzwachstum und eine deutliche Gewinnrallye. Der Umsatz stieg im Jahresvergleich um 6,5 % auf 162,8 Mio. USD, angetrieben durch ein Wachstum von 7,2 % an der Rasmussen University und 6,1 % bei APUS, während Hondros um 10,5 % zulegte. Kostendisziplin begrenzte das Gesamtausgabenwachstum auf 3,4 %, was das operative Ergebnis auf 7,0 Mio. USD gegenüber 2,2 Mio. USD im Vorjahr hob.
Der Nettogewinn stieg auf 4,5 Mio. USD (vs. 0,4 Mio.), aber ein Verlust von 3,5 Mio. USD durch die Rückzahlung aller Vorzugsaktien im Juni sowie 1,3 Mio. USD Dividenden führten zu einem Nettoverlust von 0,3 Mio. für die Stammaktionäre (-0,02 USD EPS). Für den Sechsmonatszeitraum kippte das verwässerte Ergebnis je Aktie von -0,12 auf +0,39 USD, da der Nettogewinn auf 13,4 Mio. USD sprang.
Bilanz/Liquidität: Die Barmittel stiegen auf 176,6 Mio. USD (plus 17,6 Mio. USD seit Jahresbeginn) nach einem operativen Cashflow von 51,8 Mio. USD und Immobilienverkäufen in West Virginia im Wert von 23 Mio. USD. Die Rückzahlung der Vorzugsaktien in Höhe von 39,7 Mio. USD und der damit verbundene Mittelabfluss von 43,1 Mio. USD wurden ohne neue Schulden finanziert; der Terminkreditbetrag beläuft sich weiterhin auf 96,4 Mio. USD (9,9 % SOFR + 550 Basispunkte). Die Nettoverschuldung liegt komfortabel innerhalb der 2,0×-Vereinbarung.
Segmenttrends: APUS erzielte einen operativen Gewinn von 21,4 Mio. USD (+17 %), der die geringeren operativen Verluste bei RU (-2,0 Mio.) und HCN (-0,4 Mio.) ausglich. Corporate/Andere verzeichnete einen Verlust von 12,0 Mio. USD, was die GSUSA-Aktivitäten und nicht zugeordnete Kosten widerspiegelt. Ein endgültiges Verkaufsabkommen für GSUSA wurde am 25. Juli 2025 abgeschlossen (nach dem Berichtszeitraum).
Wesentliche Erkenntnisse: Gewinnmomentum, Wegfall der Vorzugsdividenden, stärkere Cash-Generierung und bevorstehender GSUSA-Verkauf verbessern die finanzielle Flexibilität, obwohl Verluste im Pflegebereich und höhere Zinsaufwendungen weiterhin Beobachtungspunkte bleiben.
Positive
- Revenue growth of 6.5% YoY to $162.8 m with all three education segments expanding.
- Net income jumped to $4.5 m in Q2 and $13.4 m YTD, reversing prior-year weakness.
- Operating cash flow rose 56% to $51.8 m, boosting cash to $176.6 m.
- Preferred stock fully redeemed, eliminating $5-6 m annual dividend burden.
- Real-estate sales generated $23 m, and GSUSA divestiture (closed July 25) streamlines focus and adds further cash.
- RU & HCN losses narrowed, indicating early traction on turnaround efforts.
Negative
- Net loss to common shareholders of $0.3 m (-$0.02 EPS) driven by $3.5 m redemption charge.
- Interest expense increased to $2.0 m YTD amid 9.94% floating-rate debt.
- Nursing segments (RU/HCN) still generated operating losses totalling $2.4 m in Q2.
- Total assets declined $32.7 m YTD as asset sales funded financing outflows.
- Modest revenue growth (6.5%) may limit operating leverage if cost controls falter.
Insights
TL;DR: Revenue up 6.5%, cash up, preferred repaid; core EPS still thin but improving.
APEI posted its second consecutive quarter of revenue acceleration and returned to positive YTD EPS. Gross profit expanded 240 bp as selling and G&A grew slower than sales. The $43 m preferred redemption eliminates a 10% coupon, adding roughly $5 m annual after-tax savings. Importantly, operating cash flow covered capex, dividends, and most of the redemption, leaving $175 m liquidity for bolt-ons or debt reduction. Segment data show APUS remains the earnings engine; nurse-education (RU/HCN) needs further scale to break even, but Q2 losses narrowed meaningfully. At 0.3× net-cash/equity, leverage looks manageable even with SOFR near 5%. Guidance was not provided, yet run-rate margins imply FY25 EPS potential above $0.90 if trends hold.
TL;DR: Solid demand across military and nursing, but RU/HCN profitability still lagging.
Military-focused APUS continues to benefit from stable DoD Tuition Assistance and VA benefits, while nursing enrollment gains drove double-digit revenue growth at HCN. Rasmussen’s 12% revenue lift suggests brand recovery after prior regulatory headwinds, yet operating loss shows campus network still right-sizing. The shift to online and hybrid curricula supports margin upside once fixed campus leases roll off (no new lease losses this quarter). Sale of GSUSA allows management to focus on core accredited degree units. Regulatory exposure remains moderate; release of RU’s $25 m ED LOC underscores improved composite score. Overall trajectory is positive, but sustained execution in nursing programs is essential.
Il 10-Q di APEI per il Q2-25 mostra una solida crescita dei ricavi e un netto recupero degli utili. I ricavi sono aumentati del 6,5% su base annua, raggiungendo 162,8 milioni di dollari, grazie a una crescita del 7,2% all'Università Rasmussen e del 6,1% ad APUS, mentre Hondros ha registrato un incremento del 10,5%. La disciplina nei costi ha limitato la crescita delle spese totali al 3,4%, portando il reddito operativo a 7,0 milioni di dollari rispetto ai 2,2 milioni dell'anno precedente.
L'utile netto è salito a 4,5 milioni di dollari (contro 0,4 milioni), ma una perdita di 3,5 milioni legata al rimborso di tutte le azioni privilegiate a giugno e dividendi per 1,3 milioni hanno prodotto una perdita netta di 0,3 milioni disponibile per gli azionisti ordinari (-0,02 dollari per azione). Nel semestre, l'utile per azione diluito è passato da -0,12 a +0,39 dollari, grazie a un aumento dell'utile netto a 13,4 milioni.
Bilancio/liquidità: La liquidità è salita a 176,6 milioni di dollari (in aumento di 17,6 milioni da inizio anno) dopo un flusso di cassa operativo di 51,8 milioni e vendite immobiliari in West Virginia per 23 milioni. Il rimborso di azioni privilegiate per 39,7 milioni e il relativo esborso in contanti di 43,1 milioni sono stati finanziati senza nuovo debito; il capitale residuo del prestito a termine è di 96,4 milioni (9,9% SOFR + 550 punti base). La leva finanziaria netta resta comodamente entro il covenant di 2,0×.
Tendenze dei segmenti: APUS ha generato un utile operativo di 21,4 milioni (+17%), compensando le perdite operative più contenute di RU (-2,0 milioni) e HCN (-0,4 milioni). Corporate/Altro ha registrato una perdita di 12,0 milioni, riflettendo l'attività di GSUSA e costi non allocati. Un accordo definitivo per la vendita di GSUSA è stato chiuso il 25 luglio 2025 (dopo il periodo).
Punti chiave: L'impulso degli utili, la rimozione dei dividendi privilegiati, una generazione di cassa più solida e la prossima cessione di GSUSA migliorano la flessibilità finanziaria, anche se le perdite nel segmento infermieristico e l'aumento degli oneri finanziari restano aspetti da monitorare.
El 10-Q del segundo trimestre de 2025 de APEI muestra un sólido crecimiento en ingresos y una fuerte recuperación de ganancias. Los ingresos aumentaron un 6,5% interanual hasta 162,8 millones de dólares, impulsados por un crecimiento del 7,2% en Rasmussen University y del 6,1% en APUS, mientras que Hondros creció un 10,5%. La disciplina en los costos limitó el crecimiento total de gastos al 3,4%, elevando el ingreso operativo a 7,0 millones frente a 2,2 millones del año anterior.
El ingreso neto se disparó a 4,5 millones (vs. 0,4 millones), pero una pérdida de 3,5 millones por el rescate en junio de todas las acciones preferentes y 1,3 millones en dividendos generaron una pérdida neta de 0,3 millones disponible para los accionistas comunes (-0,02 EPS). En el período de seis meses, el EPS diluido pasó de -0,12 a +0,39, ya que el ingreso neto aumentó a 13,4 millones.
Balance/liquidez: El efectivo subió a 176,6 millones (un aumento de 17,6 millones en el año) tras un flujo de caja operativo de 51,8 millones y ventas inmobiliarias en Virginia Occidental por 23 millones. El rescate de acciones preferentes de 39,7 millones y la salida de efectivo relacionada de 43,1 millones se financiaron sin nueva deuda; el principal del préstamo a plazo sigue en 96,4 millones (9,9% SOFR + 550 pb). El apalancamiento neto se mantiene cómodamente dentro del convenio de 2,0×.
Tendencias por segmento: APUS generó una ganancia operativa de 21,4 millones (+17%), compensando las menores pérdidas operativas en RU (-2,0 millones) y HCN (-0,4 millones). Corporate/Otros registró una pérdida de 12,0 millones, reflejando la actividad de GSUSA y costos no asignados. Se cerró un acuerdo definitivo para vender GSUSA el 25 de julio de 2025 (posterior al período).
Conclusiones clave: El impulso en ganancias, la eliminación de dividendos preferentes, una generación de efectivo más fuerte y la próxima desinversión de GSUSA mejoran la flexibilidad financiera, aunque las pérdidas en el segmento de enfermería y el aumento de gastos por intereses siguen siendo puntos a vigilar.
APEI의 2025년 2분기 10-Q 보고서는 견고한 매출 성장과 급격한 수익 반등을 보여줍니다. 매출은 전년 대비 6.5% 증가한 1억 6,280만 달러로, Rasmussen University는 7.2%, APUS는 6.1%, Hondros는 10.5% 성장했습니다. 비용 관리로 총 비용 증가율은 3.4%에 그쳐 영업이익은 700만 달러로 전년 220만 달러에서 크게 상승했습니다.
순이익은 450만 달러로 급증했으나(전년 40만 달러), 6월에 모든 우선주 상환으로 인한 350만 달러 손실과 130만 달러 배당금으로 인해 보통주주에게 귀속되는 순손실 30만 달러(-주당순손실 0.02달러)가 발생했습니다. 6개월 기간 동안 희석 주당순이익은 -0.12달러에서 +0.39달러로 전환되었으며, 순이익은 1,340만 달러로 증가했습니다.
재무상태/유동성: 현금은 1억 7,660만 달러로(연초 대비 1,760만 달러 증가), 영업현금흐름 5,180만 달러와 웨스트버지니아 부동산 매각 2,300만 달러 덕분입니다. 3,970만 달러 우선주 상환과 관련 현금 유출 4,310만 달러는 신규 부채 없이 조달되었으며, 장기 대출 원금은 9,640만 달러(9.9% SOFR+550bp)로 유지되고 있습니다. 순 레버리지는 2.0배 계약 조건 내에서 안정적입니다.
사업부 동향: APUS는 2,140만 달러 영업이익(+17%)을 기록해 RU(-200만 달러)와 HCN(-40만 달러)의 영업손실 축소를 상쇄했습니다. Corporate/기타 부문은 GSUSA 활동 및 미배분 비용으로 1,200만 달러 손실을 냈습니다. GSUSA 매각에 대한 확정 계약은 2025년 7월 25일에 체결되었습니다(분기 이후).
주요 시사점: 수익 모멘텀, 우선주 배당 중단, 강한 현금 창출 및 예정된 GSUSA 매각은 재무 유연성을 개선하지만, 간호 부문의 손실과 이자 비용 증가는 계속 주시해야 할 사항입니다.
Le rapport 10-Q du deuxième trimestre 2025 d’APEI montre une croissance solide du chiffre d’affaires et un net rebond des bénéfices. Le chiffre d’affaires a augmenté de 6,5 % en glissement annuel pour atteindre 162,8 millions de dollars, porté par une croissance de 7,2 % à l’Université Rasmussen et de 6,1 % chez APUS, tandis que Hondros a progressé de 10,5 %. La discipline des coûts a limité la croissance des dépenses totales à 3,4 %, faisant passer le résultat opérationnel à 7,0 millions de dollars contre 2,2 millions l’année précédente.
Le résultat net a bondi à 4,5 millions de dollars (contre 0,4 million), mais une perte de 3,5 millions liée au rachat en juin de toutes les actions privilégiées et des dividendes de 1,3 million ont produit une perte nette de 0,3 million disponible pour les actionnaires ordinaires (-0,02 $ par action). Sur six mois, le BPA dilué est passé de -0,12 à +0,39 $ grâce à une hausse du résultat net à 13,4 millions.
Bilan/liquidité : La trésorerie a grimpé à 176,6 millions de dollars (en hausse de 17,6 millions depuis le début de l’année) après un flux de trésorerie opérationnel de 51,8 millions et des ventes immobilières en Virginie-Occidentale pour 23 millions. Le rachat des actions privilégiées de 39,7 millions et la sortie de trésorerie associée de 43,1 millions ont été financés sans nouvelle dette ; le principal du prêt à terme reste à 96,4 millions (9,9 % SOFR + 550 points de base). L’effet de levier net reste confortablement en dessous du covenant de 2,0×.
Tendances par segment : APUS a généré un résultat opérationnel de 21,4 millions (+17 %), compensant les pertes opérationnelles réduites de RU (-2,0 millions) et HCN (-0,4 million). Corporate/Autres a enregistré une perte de 12,0 millions, reflétant l’activité de GSUSA et des coûts non alloués. Un accord définitif pour la vente de GSUSA a été conclu le 25 juillet 2025 (après la période).
Points clés : La dynamique des bénéfices, la suppression des dividendes privilégiés, une génération de trésorerie plus forte et la cession imminente de GSUSA améliorent la flexibilité financière, bien que les pertes dans le segment des soins infirmiers et la hausse des charges d’intérêts restent des points à surveiller.
APEI’s 10-Q für Q2-25 zeigt solides Umsatzwachstum und eine deutliche Gewinnrallye. Der Umsatz stieg im Jahresvergleich um 6,5 % auf 162,8 Mio. USD, angetrieben durch ein Wachstum von 7,2 % an der Rasmussen University und 6,1 % bei APUS, während Hondros um 10,5 % zulegte. Kostendisziplin begrenzte das Gesamtausgabenwachstum auf 3,4 %, was das operative Ergebnis auf 7,0 Mio. USD gegenüber 2,2 Mio. USD im Vorjahr hob.
Der Nettogewinn stieg auf 4,5 Mio. USD (vs. 0,4 Mio.), aber ein Verlust von 3,5 Mio. USD durch die Rückzahlung aller Vorzugsaktien im Juni sowie 1,3 Mio. USD Dividenden führten zu einem Nettoverlust von 0,3 Mio. für die Stammaktionäre (-0,02 USD EPS). Für den Sechsmonatszeitraum kippte das verwässerte Ergebnis je Aktie von -0,12 auf +0,39 USD, da der Nettogewinn auf 13,4 Mio. USD sprang.
Bilanz/Liquidität: Die Barmittel stiegen auf 176,6 Mio. USD (plus 17,6 Mio. USD seit Jahresbeginn) nach einem operativen Cashflow von 51,8 Mio. USD und Immobilienverkäufen in West Virginia im Wert von 23 Mio. USD. Die Rückzahlung der Vorzugsaktien in Höhe von 39,7 Mio. USD und der damit verbundene Mittelabfluss von 43,1 Mio. USD wurden ohne neue Schulden finanziert; der Terminkreditbetrag beläuft sich weiterhin auf 96,4 Mio. USD (9,9 % SOFR + 550 Basispunkte). Die Nettoverschuldung liegt komfortabel innerhalb der 2,0×-Vereinbarung.
Segmenttrends: APUS erzielte einen operativen Gewinn von 21,4 Mio. USD (+17 %), der die geringeren operativen Verluste bei RU (-2,0 Mio.) und HCN (-0,4 Mio.) ausglich. Corporate/Andere verzeichnete einen Verlust von 12,0 Mio. USD, was die GSUSA-Aktivitäten und nicht zugeordnete Kosten widerspiegelt. Ein endgültiges Verkaufsabkommen für GSUSA wurde am 25. Juli 2025 abgeschlossen (nach dem Berichtszeitraum).
Wesentliche Erkenntnisse: Gewinnmomentum, Wegfall der Vorzugsdividenden, stärkere Cash-Generierung und bevorstehender GSUSA-Verkauf verbessern die finanzielle Flexibilität, obwohl Verluste im Pflegebereich und höhere Zinsaufwendungen weiterhin Beobachtungspunkte bleiben.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
(Mark One)
| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | ||||||||
| SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the quarterly period ended June 30, 2025
or
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE | ||||||||
| SECURITIES EXCHANGE ACT OF 1934 | ||||||||
For the transition period from ______ to ______
Commission File Number: 001-33810
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (I.R.S. Employer | ||||
| incorporation or organization) | Identification No.) | ||||
| (Address of principal executive offices) | (Zip Code) | ||||
(304 ) 724-3700
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer | ☐ | ☒ | |||||||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company | |||||||||||||||
| Emerging growth company | |||||||||||||||||
If an emerging growth company indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The total number of shares of common stock outstanding as of August 1, 2025 was 18,067,134 .
AMERICAN PUBLIC EDUCATION, INC.
FORM 10-Q
INDEX
| Page | |||||
PART I – FINANCIAL INFORMATION | |||||
Item 1. Financial Statements | 3 | ||||
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations | 24 | ||||
Item 3. Quantitative and Qualitative Disclosures About Market Risk | 39 | ||||
Item 4. Controls and Procedures | 39 | ||||
PART II – OTHER INFORMATION | |||||
Item 1. Legal Proceedings | 40 | ||||
Item 1A. Risk Factors | 40 | ||||
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds | 42 | ||||
Item 3. Defaults Upon Senior Securities | 42 | ||||
Item 4. Mine Safety Disclosures | 42 | ||||
Item 5. Other Information | 43 | ||||
Item 6. Exhibits | 44 | ||||
SIGNATURES | 45 | ||||
2
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Balance Sheets
(In thousands, except share and per share amounts)
| As of June 30, 2025 | As of December 31, 2024 | ||||||||||
| ASSETS | (Unaudited) | ||||||||||
| Current assets: | |||||||||||
| Cash, cash equivalents, and restricted cash (Note 2) | $ | $ | |||||||||
Accounts receivable, net of allowance of $ | |||||||||||
| Prepaid expenses | |||||||||||
| Income tax receivable | |||||||||||
| Assets held for sale | |||||||||||
| Total current assets | |||||||||||
| Property and equipment, net | |||||||||||
| Operating lease assets, net | |||||||||||
| Deferred income taxes | |||||||||||
| Intangible assets, net | |||||||||||
| Goodwill | |||||||||||
| Other assets, net | |||||||||||
| Total assets | $ | $ | |||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable | $ | $ | |||||||||
| Accrued compensation and benefits | |||||||||||
| Accrued liabilities | |||||||||||
| Deferred revenue and student deposits | |||||||||||
| Lease liabilities, current | |||||||||||
| Total current liabilities | |||||||||||
| Lease liabilities, long-term | |||||||||||
| Long-term debt, net | |||||||||||
| Total liabilities | |||||||||||
| Commitments and contingencies (Note 10) | |||||||||||
| Stockholders’ equity: | |||||||||||
Preferred stock, $ | |||||||||||
Common stock, $ | |||||||||||
| Additional paid-in capital | |||||||||||
| Accumulated other comprehensive loss | ( | ( | |||||||||
| Accumulated deficit | ( | ( | |||||||||
| Total stockholders’ equity | |||||||||||
| Total liabilities and stockholders’ equity | $ | $ | |||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
3
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Statements of Income
(In thousands, except per share amounts)
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| Revenue | $ | $ | $ | $ | |||||||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Instructional costs and services | |||||||||||||||||||||||
| Selling and promotional | |||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||
| Depreciation and amortization | |||||||||||||||||||||||
| Loss on assets held for sale (Note 4) | |||||||||||||||||||||||
| Loss on leases (Note 5) | |||||||||||||||||||||||
| Loss on disposals of long-lived assets | |||||||||||||||||||||||
| Total costs and expenses | |||||||||||||||||||||||
| Income from operations before interest and income taxes | |||||||||||||||||||||||
| Interest expense, net | ( | ( | ( | ( | |||||||||||||||||||
| Income before income taxes | |||||||||||||||||||||||
| Income tax expense (benefit) | ( | ||||||||||||||||||||||
| Equity investment loss | ( | ( | |||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Preferred stock dividends | |||||||||||||||||||||||
| Loss on redemption of preferred stock | |||||||||||||||||||||||
| Net (loss) income available to common stockholders | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| (Loss) income per common share: | |||||||||||||||||||||||
| Basic | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Diluted | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Weighted average number of common shares: | |||||||||||||||||||||||
| Basic | |||||||||||||||||||||||
| Diluted | |||||||||||||||||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
4
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Statements of Comprehensive Income (Loss)
(In thousands)
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||
| (Unaudited) | (Unaudited) | |||||||||||||||||||
| Net income | $ | $ | $ | $ | ||||||||||||||||
| Other comprehensive gain (loss), net of tax: | ||||||||||||||||||||
| Unrealized gain (loss) on hedging derivatives | ( | |||||||||||||||||||
| Tax effect | ( | ( | ||||||||||||||||||
| Unrealized gain (loss) on hedging derivatives, net of taxes | ( | |||||||||||||||||||
| Reclassification of loss (gain) to net income | ( | ( | ||||||||||||||||||
| Tax effect | ( | |||||||||||||||||||
| Reclassifications of loss (gain) to net income, net of taxes | ( | ( | ||||||||||||||||||
| Total other comprehensive gain (loss) | ( | ( | ( | |||||||||||||||||
| Comprehensive income (loss) | $ | $ | ( | $ | $ | |||||||||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
5
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Statements of Stockholders’ Equity (Unaudited)
(In thousands, except share amounts)
| Additional Paid-in Capital | Accumulated Other Comprehensive Income (loss) | Accumulated Deficit | Total Stockholders’ Equity | ||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2024 | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Preferred stock dividends | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
| Issuance of common stock under employee benefit plans | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||||
| Deemed repurchased shares of common and restricted stock for tax withholding | — | — | ( | ( | ( | — | — | ( | |||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2025 | $ | $ | $ | $ | ( | $ | ( | $ | |||||||||||||||||||||||||||||||||
| Preferred stock dividends | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Redemption of preferred stock | ( | ( | — | — | — | — | — | ( | |||||||||||||||||||||||||||||||||
| Loss on redemption of preferred stock | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
| Issuance of common stock under employee benefit plans | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Deemed repurchased shares of common and restricted stock for tax withholding | — | — | ( | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2025 | $ | $ | $ | ( | $ | ( | $ | ||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
6
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Statements of Stockholders’ Equity (Unaudited)
(In thousands, except share amounts)
| Additional Paid-in Capital | Accumulated Other Comprehensive Income (loss) | Accumulated Deficit | Total Stockholders’ Equity | ||||||||||||||||||||||||||||||||||||||
| Preferred Stock | Common Stock | ||||||||||||||||||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | ||||||||||||||||||||||||||||||||||||||
| Balance as of December 31, 2023 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
| Preferred stock dividends | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Issuance of common stock under employee benefit plans | — | — | ( | — | — | ||||||||||||||||||||||||||||||||||||
| Deemed repurchased shares of common and restricted stock for tax withholding | — | — | ( | ( | ( | — | — | ( | |||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Repurchased and retired shares of common stock | — | — | ( | ( | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Balance as of March 31, 2024 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
| Preferred stock dividends | — | — | — | — | — | — | ( | ( | |||||||||||||||||||||||||||||||||
| Exercise of stock options | — | — | — | — | — | ||||||||||||||||||||||||||||||||||||
| Issuance of common stock under employee benefit plans | — | — | — | — | |||||||||||||||||||||||||||||||||||||
| Deemed repurchased shares of common and restricted stock for tax withholding | — | — | ( | ( | — | — | ( | ||||||||||||||||||||||||||||||||||
| Stock-based compensation | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Other comprehensive loss | — | — | — | — | — | ( | — | ( | |||||||||||||||||||||||||||||||||
| Net income | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||
| Balance as of June 30, 2024 | $ | $ | $ | $ | $ | ( | $ | ||||||||||||||||||||||||||||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
7
AMERICAN PUBLIC EDUCATION, INC.
Consolidated Statements of Cash Flows
(In thousands)
| Six Months Ended June 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| (Unaudited) | |||||||||||
| Operating activities | |||||||||||
| Net income | $ | $ | |||||||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||||
| Depreciation and amortization | |||||||||||
| Amortization of debt issuance costs | |||||||||||
| Stock-based compensation | |||||||||||
| Equity investment loss | |||||||||||
| Deferred income taxes | |||||||||||
| Loss on assets held for sale | |||||||||||
| Loss on disposals of long-lived assets | |||||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Accounts receivable, net of allowance for bad debt | |||||||||||
| Prepaid expenses | ( | ( | |||||||||
| Income tax receivable/payable | ( | ( | |||||||||
| Operating leases, net | ( | ||||||||||
| Other assets | ( | ( | |||||||||
| Accounts payable | ( | ||||||||||
| Accrued compensation and benefits | ( | ||||||||||
| Accrued liabilities | |||||||||||
| Deferred revenue and student deposits | |||||||||||
| Net cash provided by operating activities | |||||||||||
| Investing activities | |||||||||||
| Capital expenditures | ( | ( | |||||||||
| Proceeds from the sale of real property | |||||||||||
| Net cash provided by (used in) investing activities | ( | ||||||||||
| Financing activities | |||||||||||
| Cash paid for repurchase of common stock | ( | ( | |||||||||
| Cash received from exercise of stock options | |||||||||||
| Preferred stock dividends paid | ( | ( | |||||||||
| Cash paid for redemption of preferred stock | ( | ||||||||||
| Cash paid for principal on borrowings and finance leases | ( | ( | |||||||||
| Net cash used in financing activities | ( | ( | |||||||||
| Net increase in cash, cash equivalents, and restricted cash | |||||||||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | $ | |||||||||
| Supplemental disclosure of cash flow information | |||||||||||
| Interest paid | $ | $ | |||||||||
| Income taxes paid | $ | $ | |||||||||
The accompanying notes are an integral part of these Consolidated Financial Statements.
8
AMERICAN PUBLIC EDUCATION, INC.
Notes to Consolidated Financial Statements
Note 1. Nature of the Business
American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the “Company,” is a provider of online and campus-based postsecondary education and career learning to students through the following subsidiary institutions:
•American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military, veterans, extended military families, and other public service and service-minded communities, through American Military University, or AMU, and American Public University, or APU. APUS is institutionally accredited by the Higher Learning Commission, or HLC.
•Rasmussen College, LLC, which is referred to herein as Rasmussen University, or RU, a nursing- and health sciences-focused institution, provides postsecondary education to students at 20 campuses in six states and online. RU is institutionally accredited by HLC.
•National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN, provides nursing education to students at eight campuses in three states. HCN is institutionally accredited by the Accrediting Bureau for Health Education Schools, or ABHES.
•American Public Training LLC, which is referred to herein as Graduate School USA, or GSUSA, provides career learning and leadership training in-person and online to the federal workforce. GSUSA is accredited by the Accrediting Council for Continuing Education and Training, or ACCET. In July 2025, APEI entered into a definitive agreement to sell all of its membership interest in GSUSA, and the sale was completed on July 25, 2025. Please refer to “Note 13. Subsequent Events” for more information.
The Company’s subsidiary institutions are licensed or otherwise authorized by state authorities to offer education programs to the extent the institutions believe such licenses or authorizations are required, and APUS, RU, and HCN are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs.
The Company’s operations are organized into the following reportable segments:
•American Public University System Segment, or APUS Segment. This segment reflects the operational activities of APUS.
•Rasmussen University Segment, or RU Segment. This segment reflects the operational activities of RU.
•Hondros College of Nursing Segment, or HCN Segment. This segment reflects the operational activities of HCN.
Adjustments to reconcile segment results to the Consolidated Financial Statements are included in Corporate and Other. These adjustments include unallocated corporate activity and eliminations, and the operational activities of GSUSA. GSUSA operates as a stand-alone subsidiary of APEI but does not meet the quantitative thresholds to qualify as a reportable segment and does not have other requisite characteristics as a reportable segment. Therefore, GSUSA’s results are combined with and presented within Corporate and Other.
Note 2. Summary of Significant Accounting Policies
A summary of the Company’s significant accounting policies follows:
Basis of Presentation and Accounting
9
Business Combinations
The Company accounts for business combinations in accordance with Financial Accounting Standards Board Accounting Standards Codification 805, Business Combinations, or FASB ASC 805, which requires the acquisition method to be used for all business combinations. Under ASC 805, the assets and liabilities of an acquired company are reported at business fair value along with the fair value of acquired intangible assets at the date of acquisition.
Principles of Consolidation
The accompanying unaudited interim Consolidated Financial Statements include the accounts of APEI and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.
Unaudited Interim Consolidated Financial Information
The unaudited interim Consolidated Financial Statements do not include all the information and notes required by GAAP for audited annual financial statement presentations. In the opinion of management, these statements include all adjustments (consisting of normal recurring adjustments) considered necessary to present a fair statement of the Company’s financial position, results of operations, and cash flows. Operating results for any interim period are not necessarily indicative of the results that may be expected for future periods, including the year ending December 31, 2025. This Quarterly Report on Form 10-Q, or this Quarterly Report, should be read in conjunction with the Consolidated Financial Statements and accompanying notes in its audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, or the Annual Report.
Use of Estimates
In preparing financial statements in conformity with GAAP, the Company is required to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. The Company evaluates these estimates and assumptions on an ongoing basis and bases its estimates on experience, current and expected future conditions and various other assumptions that the Company believes are reasonable under the circumstances. Actual results may differ from those estimates under different assumptions or conditions, and the impact of such differences may be material to the Consolidated Financial Statements.
Cash and Cash Equivalents
The Company considers all short-term highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash and cash equivalents consist of demand deposits with financial institutions, money market funds, and U.S. Treasury bills. Cash and cash equivalents are Level 1 assets in the fair value reporting hierarchy.
Restricted Cash
10
Cash and cash equivalents and restricted cash as of June 30, 2025, and December 31, 2024, were as follows (in thousands):
| As of June 30, 2025 | As of December 31, 2024 | ||||||||||
| (Unaudited) | |||||||||||
| Cash, cash equivalents, and restricted cash | $ | $ | |||||||||
| Less: restricted cash | ( | ( | |||||||||
| Total unrestricted cash | $ | $ | |||||||||
Assets Held for Sale
Assets held for sale at December 31, 2024 represent excess real property located in Charles Town, West Virginia for the Company’s APUS Segment. Long-lived assets are classified as held for sale when the assets are expected to be sold within the next 12 months and meet the other relevant held for sale criteria. As such, properties are recorded at the lower of the carrying value or fair value, less costs to sell, until such time the assets are sold. The Company completed the sale of its remaining assets held for sale in June 2025.
Goodwill and Intangible Assets
Goodwill represents the excess of the purchase price of an acquired business over the amount assigned to the tangible and identified intangible assets acquired and liabilities assumed based on their estimated fair values. Goodwill and indefinite-lived intangible assets are not amortized. The Company accounts for goodwill and indefinite-lived intangible assets in accordance with FASB ASC 350, Intangibles Goodwill and Other, and Accounting Standards Update, or ASU, 2017-04, Intangibles – Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment. The Company’s goodwill and intangible assets are deductible for tax purposes.
Indefinite-lived and finite-lived intangible assets acquired in business combinations are recorded at fair value on the acquisition date. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful life of the asset.
The Company annually assesses goodwill and intangible assets for impairment in the fourth quarter, or more frequently if events or circumstances indicate that goodwill might be impaired or the carrying amount of an asset may not be recoverable. Goodwill impairment testing consists of an optional qualitative assessment as well as a quantitative test. The quantitative test compares the fair value of a reporting unit to its carrying value. If the carrying value of the reporting unit is greater than zero and its fair value is greater than its carrying amount, there is no impairment. If the carrying value is greater than the fair value, and such assets are not recoverable, the difference between the two values is recorded as an impairment.
For additional details regarding goodwill and intangible assets, please refer to “Note 6. Goodwill and Intangible Assets” to the Consolidated Financial Statements.
Investments
Prior to December 31, 2024, the Company accounted for its investments in less than majority owned companies in accordance with FASB ASC 323, Investments – Equity Method and Joint Ventures and FASB ASC 321, Investments – Equity Securities. The Company applied ASC 323 to investments when it had the ability to exercise significant influence but did not control the operating and financial policies of the company, which was generally represented by equity ownership of at least 20 percent but not more than 50 percent. Investments accounted for under the equity method were initially recorded at cost and subsequently adjusted by the Company’s share of equity in income or losses after the date of acquisition. The pro rata share of the operating results of the investee was reported in the accompanying Consolidated Statements of Income as equity investment income or loss. Investments that did not meet the equity method requirements were accounted for using the cost method under ASC 321 with changes in the fair value of the investment reported in the accompanying Consolidated Statements of Income as equity investment income or loss.
During the first quarter of 2024, the Company evaluated its equity investments for indicators of impairment and concluded the fair value of a cost method investment was less than its carrying amount. As a result, the Company recorded an investment loss of $3.3 million during the first quarter of 2024 on a 2015 cost method investment. This investment loss was due to the investee entering into a new convertible debt agreement that resulted in the conversion of the Company’s preferred stock
11
holdings in the investee into common shares, and the dilution of the Company’s ownership percentage. The investment loss recorded reduced the book value of the cost method investment to zero.
Stock-based Compensation
The Company accounts for stock-based compensation in accordance with FASB ASC 718, Stock Compensation, which requires companies to expense share-based compensation based on fair value, and ASU 2016-09, Compensation-Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting. Stock-based payments may include incentive stock options or non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, performance shares, performance units, cash-based awards, other stock-based awards, including unrestricted shares, or any combination of the foregoing.
Stock-based compensation cost is recognized as an expense generally over a three-year vesting period using the straight-line method for employees and the graded-vesting method for members of the Company’s Board of Directors, or the Board. It is measured using the Company’s closing stock price on the date of the grant. An accelerated one-year period is used to recognize stock-based compensation cost for employees who have reached certain service and retirement eligibility criteria on the date of grant. The fair value of each option award is estimated at the date of grant using a Black-Scholes option-pricing model that uses certain assumptions. The Company makes assumptions with respect to expected stock price volatility based on the average historical volatility of the Company’s common stock. In addition, the Company determines the risk-free interest rate by selecting the U.S. Treasury constant maturity for the same maturity as the estimated life of the option quoted on an investment basis in effect at the time of grant for that business day.
Judgment is required in estimating the percentage of share-based awards that are expected to vest, and in the case of performance stock units, or PSUs, the level of performance that will be achieved and the number of shares that will be earned. The Company estimates forfeitures of share-based awards at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from original estimates. The forfeiture assumption is ultimately adjusted to the actual forfeiture rate. If actual results differ significantly from these estimates, stock-based compensation expense could be higher or lower and have a material impact on the Consolidated Financial Statements. Estimates of fair value are subjective and are not intended to predict actual future events, and subsequent events are not indicative of the reasonableness of the original estimates of fair value made under ASC 718.
Stock-based compensation expense for the three and six months ended June 30, 2025, and 2024 was as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| Instructional costs and services | $ | $ | $ | $ | |||||||||||||||||||
| Selling and promotional | |||||||||||||||||||||||
| General and administrative | |||||||||||||||||||||||
| Total stock-based compensation expense | $ | $ | $ | $ | |||||||||||||||||||
Incentive-based Compensation
The Company provides incentive-based compensation opportunities to certain employees through cash incentive and equity awards. The expense associated with these awards is reflected within the Company’s operating expenses. For the years ending December 31, 2025, and 2024, the Management Development and Compensation Committee of the Board approved annual incentive arrangements for senior management employees. The aggregate amount of awards payable, if any, is dependent upon the achievement of certain Company financial and operational goals and the satisfaction of individual performance goals. Given that the awards are generally contingent upon achieving annual objectives, final determination of the current year incentive awards cannot be made until after the results for the year are finalized. The Company recognizes the
12
estimated fair value of performance-based restricted stock units by assuming the satisfaction of any performance-based objectives at the “target” level, which is the most probable outcome determined for accounting purposes at the time of grant and multiplying the corresponding number of shares earned based upon such achievement by the closing price of the Company’s stock on the date of grant. To the extent performance goals are not met, compensation cost is not ultimately recognized against the goals and, to the extent previously recognized, compensation cost is reversed. Amounts accrued are subject to change in future interim periods if actual future financial results or operational performance are better or worse than expected. During the three and six months ended June 30, 2025, the Company recognized an aggregate incentive-based compensation expense of $2.9 million and $4.7 million, respectively, compared to an aggregate expense of $1.9 million and $3.8 million for the three and six months ended June 30, 2024, respectively.
Income Taxes
The Company accounts for income taxes in accordance with FASB ASC 740, Accounting for Income Taxes. The Company determines its interim tax provision by applying the estimated income tax rate expected for the full calendar year to income before income taxes for the period adjusted for discrete items.
Recent Accounting Pronouncements
The Company considers the applicability and impact of all ASUs issued by the FASB. All ASUs issued subsequent to the filing of the Annual Report on March 6, 2025, were assessed and determined to be either inapplicable or not expected to have a material impact on the Company’s consolidated financial position and/or results of operations.
Note 3. Revenue
Disaggregation of Revenue
| Three Months Ended June 30, 2025 | |||||||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||||||
| APUS | RU | HCN | Corporate and Other | Consolidated | |||||||||||||||||||||||||
| Instructional services, net of grants and scholarships | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Graduation fees | |||||||||||||||||||||||||||||
| Textbook and other course materials | |||||||||||||||||||||||||||||
| Other fees | |||||||||||||||||||||||||||||
| Total Revenue | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Three Months Ended June 30, 2024 | |||||||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||||||
| APUS | RU | HCN | Corporate and Other | Consolidated | |||||||||||||||||||||||||
| Instructional services, net of grants and scholarships | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Graduation fees | |||||||||||||||||||||||||||||
| Textbook and other course materials | |||||||||||||||||||||||||||||
| Other fees | |||||||||||||||||||||||||||||
| Total Revenue | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
13
| Six Months Ended June 30, 2025 | |||||||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||||||
| APUS | RU | HCN | Corporate and Other | Consolidated | |||||||||||||||||||||||||
| Instructional services, net of grants and scholarships | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Graduation fees | |||||||||||||||||||||||||||||
| Textbook and other course materials | |||||||||||||||||||||||||||||
| Other fees | |||||||||||||||||||||||||||||
| Total Revenue | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Six Months Ended June 30, 2024 | |||||||||||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||||||||
| APUS | RU | HCN | Corporate and Other | Consolidated | |||||||||||||||||||||||||
| Instructional services, net of grants and scholarships | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
| Graduation fees | |||||||||||||||||||||||||||||
| Textbook and other course materials | |||||||||||||||||||||||||||||
| Other fees | |||||||||||||||||||||||||||||
| Total Revenue | $ | $ | $ | $ | $ | ||||||||||||||||||||||||
Corporate and Other includes tuition and contract training revenue earned by GSUSA and the elimination of intersegment revenue for courses taken by employees of one segment at other segments.
Contract Balances and Performance Obligations
The Company had no
The Company recognizes a contract liability, or deferred revenue, when a student begins a course, in the case of APUS and GSUSA, or starts a term, in the case of RU and HCN. Deferred revenue at June 30, 2025, was $25.0 million and included $15.6 million in future revenue that had not yet been earned for courses and terms that were in progress, as well as $9.4 million in consideration received in advance for future courses or terms, or student deposits. Deferred revenue represents the Company’s performance obligation to transfer future instructional services to students. Deferred revenue at December 31, 2024, was $23.5 million and included $14.1 million in future revenue that had not yet been earned for courses and terms that were in progress, as well as $9.4 million in student deposits.
The Company has elected, as a practical expedient, not to disclose additional information about unsatisfied performance obligations for contracts with students that have an expected duration of one year or less.
When the Company begins providing the performance obligations, a contract receivable is created, resulting in accounts receivable on the accompanying Consolidated Balance Sheets. The Company accounts for receivables in accordance with FASB ASC 310, Receivables. The Company uses the portfolio approach, a practical expedient, to evaluate if a contract exists and to assess collectability at the time of contract inception based on historical experience. Contracts are subsequently reviewed for collectability if significant events or circumstances indicate a change.
The allowance for doubtful accounts is based on management’s evaluation of the status of existing accounts receivable. Among other factors, management considers the age of the receivable, the anticipated source of payment, and historical allowance considerations. Consideration is also given to any specific known risk areas among the existing accounts receivable balances. Recoveries of receivables previously written off are recorded when received. APUS, RU, and GSUSA do not charge interest on past due accounts receivable. HCN charges interest on payment plans when a student graduates or otherwise exits the program. Interest charged by HCN on payment plans was immaterial for the periods presented.
14
Note 4. Assets held for sale
Assets held for sale at December 31, 2024, represented excess real properties located in Charles Town, West Virginia, for the Company’s APUS Segment.
In the first quarter of 2025, APUS entered into an agreement to sell a building classified in assets held for sale as of December 31, 2024, for $7.0 million, and recorded a loss of $1.5 million, based on the contract amount less estimated costs to sell of $0.4 million. The loss is included in Loss on assets held for sale in the accompanying Consolidated Statements of Income for the six months ended June 30, 2025. APUS completed the sale in June 2025 for net sales proceeds of $6.6 million.
In the fourth quarter of 2024, APUS entered into an agreement to sell a building previously in use for $16.6 million. As a result, the building was reclassified to held for sale as of December 31, 2024 at the contract amount less estimated costs to sell of $0.7 million, or $15.9 million. APUS completed the sale in June 2025 for net sales proceeds of $15.9 million.
In the fourth quarter of 2024, APUS entered into an agreement to sell an undeveloped parcel of land for $0.5 million which approximated its carrying value. As a result, the land was classified in assets held for sale as of December 31, 2024. APUS completed the sale in February 2025 for net sales proceeds of $0.5 million.
Total cash received from the sale of assets held for sale was $23.0 million for the six months ended June 30, 2025.
Note 5. Leases
The Company has operating leases for office space and campus facilities and finance leases for certain copiers and printers. Leases are classified as operating leases unless they meet any of the criteria below to be classified as a finance lease:
•the lease transfers ownership of the asset at the end of the lease;
•the lease grants an option to purchase the asset that the lessee is expected to exercise;
•the lease term reflects a major part of the asset’s economic life;
•the present value of the lease payments equals or exceeds the fair value of the asset; or
•the asset is specialized with no alternative use to the lessor at the end of the term.
Operating Leases
The Company has operating leases for office space and campus facilities. Some leases include options to terminate or extend for or more years. These options are included in the lease term when it is reasonably certain that the option will be exercised. The Company leases corporate office space in Florida, under an operating lease that expires in January 2029. The RU Segment leases administrative office space in Minneapolis, Minnesota, and leases 20 campuses located in six states under operating leases that expire through March 2034. The HCN Segment leases administrative office space in suburban Columbus, Ohio, and leases eight campuses located in three states under operating leases that expire through December 2034. GSUSA leases classroom and administrative office space in Washington, D.C. and Honolulu, Hawaii, under operating leases that expire through September 2036.
Operating lease assets are right-of-use assets, or ROU assets, which represent the right to use an underlying asset for the lease term. Operating lease liabilities represent the obligation to make lease payments arising from the lease. Operating leases are included in the Operating lease assets, net, and Operating lease liabilities, current and long-term, on the accompanying Consolidated Balance Sheets. These assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. When the lease does not provide an implicit interest rate, the Company uses an incremental borrowing rate based on information available at lease commencement to determine the present value of the lease payments. The ROU asset includes all lease payments and excludes lease incentives.
Lease expense for operating leases is recognized on a straight-line basis over the lease term. There are no variable lease payments. Lease expense for the three and six months ended June 30, 2025 was $4.5 million and $9.4 million, respectively, compared to $4.3 million and $9.5 million for the three and six months ended June 30, 2024, respectively. These costs are primarily related to long-term operating leases but also include amounts for short-term leases with terms greater than 30 days that are not material. Cash paid for amounts included in the present value of operating lease liabilities during the three and six months ended June 30, 2025, was $4.8 million and $9.4 million, respectively, compared to $3.7 million and $8.2 million for the three and six months ended June 30, 2024, respectively, and is included in operating cash flows.
15
Loss on leases
During the three months ended March 31, 2024, the Company elected to terminate its RU Segment lease for a planned Dallas, Texas campus. The Company paid a lease termination fee of $2.2 million and recorded a loss of $2.1 million as a result of this lease termination. Additionally, in the first quarter of 2024, the Company’s RU Segment began consolidating two Minnesota campuses, and, as a result, during the three months ended June 30, 2024, the Company paid a lease termination fee of $1.2 million related to the consolidation. As a result of the consolidation and lease termination, during the three and six months ended June 30, 2024, the Company recorded a loss on leases of $0.4 million and $1.2 million, respectively.
In May 2024, RU notified the Wisconsin Educational Approval Program that it intends to voluntarily close two Wisconsin campuses, effective December 31, 2025, and 2026, respectively. As a result, the Company recorded a lease impairment of $0.4 million during the three months ended June 30, 2024.
During the three and six months ended June 30, 2024, the total loss on leases was $0.8 million and $3.7 million, respectively, and is included in Loss on leases in the Consolidated Statements of Income. There was no loss on leases during the three and six months ended June 30, 2025.
Finance Leases
The Company leases copiers and printers pursuant to leases that are classified as finance leases and that expire in 2027. The Company pledged the assets financed to secure the outstanding leases. As of June 30, 2025, the total finance lease liability was $0.3 million, with an average interest rate of 7.00 %. The ROU assets are recorded within Property and equipment, net on the accompanying Consolidated Balance Sheets. Lease amortization expense associated with the Company’s finance leases was $0.1
The following tables present information about the amount and timing of cash flows arising from the Company’s operating and finance leases as of June 30, 2025 (in thousands):
| Maturity of Lease Liabilities (Unaudited) | Operating Leases | Finance Leases | ||||||
| 2025 (remaining) | $ | $ | ||||||
| 2026 | ||||||||
| 2027 | ||||||||
| 2028 | ||||||||
| 2029 | ||||||||
| 2030 | ||||||||
| 2031 and beyond | ||||||||
| Total future minimum lease payments | $ | $ | ||||||
| Less: imputed interest | ( | ( | ||||||
| Present value of operating lease liabilities | $ | $ | ||||||
| Less: lease liabilities, current | ( | ( | ||||||
| Lease liabilities, long-term | $ | $ | ||||||
| Balance Sheet Classification (Unaudited) | |||||
| Current: | |||||
| $ | |||||
| Long-term: | |||||
| Total lease liabilities | $ | ||||
16
| Other Information (Unaudited) | |||||
| Weighted average remaining lease term (in years): | |||||
| Operating leases | |||||
| Finance leases | |||||
| Weighted average discount rate: | |||||
| Operating leases | % | ||||
| Finance leases | % | ||||
Note 6. Goodwill and Intangible Assets
During the three months ended June 30, 2025, in connection with the preparation of this Quarterly Report, the Company performed a qualitative assessment for potential impairment of the RU and HCN Segment goodwill and indefinite-lived intangible assets. As part of the assessment, the Company considered the events and circumstances expressly required by ASC 350, in addition to other entity-specific factors. Factors considered included RU and HCN’s financial and enrollment performance against internal targets, economic factors, and the continued favorable growth outlook for nursing education. After completing the qualitative review of goodwill and indefinite-lived intangible assets for the RU and HCN Segments, the Company concluded it was more likely than not that the fair value of each of the RU and HCN Segments was more than the respective carrying value, and therefore, no quantitative impairment test and no impairment charge was necessary.
The following table summarizes the carrying amount of goodwill by reportable segment (in thousands):
| APUS Segment | RU Segment | HCN Segment | Total Goodwill | |||||||||||||||||||||||
| (Unaudited) | ||||||||||||||||||||||||||
| Goodwill as of December 31, 2024 | $ | $ | $ | $ | ||||||||||||||||||||||
| Impairment | $ | |||||||||||||||||||||||||
| Goodwill as of June 30, 2025 | $ | $ | $ | $ | ||||||||||||||||||||||
Goodwill and indefinite-lived intangible assets are reviewed for impairment annually, or more frequently if events or circumstances indicate that goodwill might be impaired or the carrying amount of an asset may not be recoverable. The Company’s annual assessment during the fourth quarter of 2024 concluded that the fair value of RU and HCN exceeded their carrying values by approximately $71.9 million, or 62 %, and $8.6 million, or 24 %, respectively.
17
The following table represents the balance of the Company’s intangible assets as of June 30, 2025, and December 31, 2024 (in thousands):
| Gross Carrying Amount | Accumulated Amortization | Impairment | Net Carrying Amount | ||||||||||||||||||||
| (Unaudited) | |||||||||||||||||||||||
| Finite-lived intangible assets | |||||||||||||||||||||||
| Student roster | $ | $ | $ | — | $ | ||||||||||||||||||
Curricula | — | ||||||||||||||||||||||
| Student and customer contracts and relationships | — | ||||||||||||||||||||||
| Lead conversions | — | ||||||||||||||||||||||
Non-compete agreements | — | ||||||||||||||||||||||
| Tradename | — | ||||||||||||||||||||||
| Accreditation and licenses | — | ||||||||||||||||||||||
| Total finite-lived intangible assets | $ | $ | $ | — | $ | ||||||||||||||||||
| Indefinite-lived intangible assets | |||||||||||||||||||||||
Trade name | — | ||||||||||||||||||||||
| Accreditation, licensing, and Title IV | — | ||||||||||||||||||||||
| Affiliation agreements | — | — | |||||||||||||||||||||
Total indefinite-lived intangible assets | — | ||||||||||||||||||||||
Total intangible assets | $ | $ | $ | $ | |||||||||||||||||||
All recorded identified intangible assets with a definite useful life related to the acquisitions of RU, HCN, and GSUSA, were fully amortized as of December 31, 2024. Finite-lived intangible assets were amortized in a manner that reflected the estimated economic benefit of the intangible assets and were amortized on a straight-line basis. For the three and six months ended June 30, 2024, the Company recorded amortization expense related to definite-lived intangible assets of approximately $1.3 million and $2.5 million, respectively. For additional information on goodwill and intangible assets, see the Consolidated Financial Statements and accompanying notes in the Annual Report.
Note 7. (Loss) Income Per Common Share
(Loss) income per common share is calculated by dividing net (loss) income available to common stockholders by the weighted average number of shares of common stock outstanding during the period. Net (loss) income available to common stockholders is net (loss) income adjusted for preferred stock dividends declared and loss on redemptions of preferred stock. Diluted (loss) income per common share is calculated by dividing net (loss) income available to common stockholders by the weighted average number of shares of common stock outstanding, increased by the shares used in the per share calculation by the dilutive effects of restricted stock and option awards. The table below reflects the calculation of (loss) income per common share and the weighted average number of common shares outstanding, on an as if converted basis, used in computing basic and diluted (loss) income per common share (in thousands, expect per share amounts).
18
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| (Loss) income per common share | |||||||||||||||||||||||
| Net income | $ | $ | $ | $ | |||||||||||||||||||
| Preferred stock dividend | |||||||||||||||||||||||
| Loss on redemption of preferred stock | |||||||||||||||||||||||
| Net (loss) income available to common shareholders | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Basic weighted average shares outstanding | |||||||||||||||||||||||
| (Loss) income per common share | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Diluted (loss) income per common share | |||||||||||||||||||||||
| Net (loss) income available to common shareholders | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
| Basic weighted average shares outstanding | |||||||||||||||||||||||
| Effect of dilutive restricted stock and options | |||||||||||||||||||||||
| Diluted weighted average shares outstanding | |||||||||||||||||||||||
| Diluted (loss) income per common share | $ | ( | $ | ( | $ | $ | ( | ||||||||||||||||
The table below reflects a summary of securities that could potentially dilute basic (loss) income per common share in future periods that were not included in the computation of diluted loss per share because the effect would have been antidilutive (in thousands).
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| Antidilutive securities: | |||||||||||||||||||||||
| Stock options | |||||||||||||||||||||||
| Restricted shares | |||||||||||||||||||||||
| Total antidilutive securities | |||||||||||||||||||||||
Note 8. Long-Term Debt
In connection with the acquisition of RU, APEI, as borrower, entered into a Credit Agreement with Macquarie Capital Funding LLC, or the Credit Agreement, as administrative agent and collateral agent, or the Agent, Macquarie Capital USA Inc. and Truist Securities, Inc., as lead arrangers and joint bookrunners, and certain lenders party thereto, or the Lenders. The Credit Agreement provides for (i) a senior secured term loan facility in an aggregate original principal amount of $175.0 million, or the Term Loan, with a scheduled maturity date of September 1, 2027 and (ii) a senior secured revolving loan facility in an aggregate commitment amount of $20.0 million, or the Revolving Credit Facility, and, together with the Term Loan, is referred to as the Facilities, with a scheduled maturity date of September 1, 2026, the full capacity of which may be utilized for the issuance of letters of credit. The Revolving Credit Facility also includes a $5.0 million sub-facility for swing line loans. The Term Loan, the proceeds of which were used as part of the cash consideration for the RU acquisition, was fully funded on September 1, 2021, or the RU Closing Date, and is presented net of deferred financing fees on the accompanying Consolidated Balance Sheets. Deferred financing fees are being amortized using the effective interest method over the term of the Term Loan. As of June 30, 2025, and December 31, 2024, the remaining unamortized deferred financing fees were $2.4 million and $3.0 million, respectively. Deferred financing fees of $0.5 million related to the Revolving Credit Facility were recorded as an asset and are being amortized to interest expense over the term of the Revolving Credit Facility. There were no
Outstanding borrowings under the Facilities bear interest at a per annum rate equal to Term Secured Overnight Financing Rate, or Term SOFR, plus 5.50 % (plus a credit spread adjustment ranging from 0.11448 % to 0.42826 % depending on the interest period selected by APEI), and subject to a 0.75 % floor after giving effect to such adjustment, which shall
19
increase by an additional 2.00 % on all past due obligations if APEI fails to pay any amount when due. As of June 30, 2025, the Facilities’ borrowing rate was 9.94 %. An unused commitment fee in the amount of 0.50 % is payable quarterly in arrears based on the average daily unused amount of the commitments under the Revolving Credit Facility.
Interest expense, including offsets from the interest rate cap agreement in 2024 was $2.4 million and $4.8 million for the three and six months ended June 30, 2025, respectively, compared to $1.9 million and $3.9 million for the three and six months ended June 30, 2024, respectively.
In December 2022, APEI made prepayments totaling $65.0 million on the Term Loan. With this prepayment, APEI is not required to make quarterly principal payments on the Term Loan until payment of the outstanding principal amount at maturity in September 2027, subject to certain exceptions, including with respect to annual excess cash flows, proceeds from the sale of certain assets, casualty and condemnation events, and prohibited debt issuances. APEI had no mandatory prepayment obligation for the year ended December 31, 2024, and no mandatory prepayment obligation related to the sale of assets held for sale in 2025.
The Facilities are and will be guaranteed by APEI’s subsidiaries and certain of APEI’s future subsidiaries that are required to become a party thereto as guarantors, or Guarantors. The obligations of APEI and the Guarantors are secured by a pledge of substantially all of their respective assets, pursuant to the terms of the Collateral Agreement dated as of the RU Closing Date, by and among APEI, the Agent and the Guarantors from time to time party thereto. Effective May 2025, GSUSA was removed as a Guarantor under the Credit Agreement.
The Credit Agreement contains customary affirmative and negative covenants, including limitations on APEI’s and its subsidiaries’ abilities, among other things, to incur additional debt, grant or permit additional liens, make investments and acquisitions, merge or consolidate with others, dispose of assets, pay dividends and distributions, and enter into affiliate transactions, in each case, subject to certain exceptions, as well as customary representations, warranties, events of default, and remedies upon default, including acceleration and rights to foreclose on the collateral securing the Facilities. In addition, the Credit Agreement contains a financial covenant that requires APEI to maintain a Total Net Leverage Ratio of no greater than 2.00 to 1.00. As of June 30, 2025, the Company was in compliance with all debt covenants.
For additional information on certain restrictions placed on the Company’s indebtedness pursuant to the terms of the Company’s Series A Senior Preferred Stock prior to the redemption on June 23, 2025, please refer to “Note 12. Preferred Stock” to the Consolidated Financial Statements.
Long-term debt consists of the following as of June 30, 2025, and December 31, 2024 (in thousands):
| As of June 30, 2025 | As of December 31, 2024 | ||||||||||
| (Unaudited) | |||||||||||
| Credit agreement | $ | $ | |||||||||
| Deferred financing fees | ( | ( | |||||||||
| Total debt | |||||||||||
| Less: Current portion | |||||||||||
| Long-Term Debt | $ | $ | |||||||||
Scheduled maturities of long-term debt as of June 30, 2025, are as follows (in thousands):
| Maturities of Long-Term Debt (Unaudited) | Loan Payments | ||||
| 2027 | $ | ||||
| Total | $ | ||||
20
Derivatives and Hedging
The Company is subject to interest rate risk, as all outstanding borrowings under the Credit Agreement are subject to a variable rate of interest. On September 30, 2021, the Company entered into an interest rate cap agreement to manage its exposure to the variable rate of interest with a total notional value of $87.5 million. On June 30, 2023, in connection with the transition of the benchmark rate to Term SOFR, the Company entered into a new interest rate cap agreement, designated as a cash flow hedge, in the same notional value, to provide the Company with interest rate protection in the event that the Term SOFR rate exceeded 1.78 %. The interest rate cap agreement expired on January 1, 2025.
In January 2025, the Company entered into a new interest rate cap agreement, with a notional value of $50.0 million. This new interest rate cap agreement, designated as a cash flow hedge, provides the Company with interest rate protection in the event that the Term SOFR rate exceeds 5.00 %, and is scheduled to expire on June 30, 2026.
Changes in the fair value of the interest rate cap designated as a hedging instrument that effectively offset the variability of cash flows associated with the Company’s variable-rate long-term debt obligations are reported in accumulated other comprehensive income. These amounts subsequently are reclassified into interest expense as a yield adjustment of the hedged interest payments in the same period in which the related interest affects earnings.
Note 9. Segment Information
The Company’s Chief Executive Officer, as the chief operating decision maker, or CODM, organizes the company, manages resource allocations, and measures performance among three
The CODM reviews information about each reportable segment’s revenue and categorized expenses, and allocates resources to, and measures the performance of, each reportable segment using reportable segment operating income (loss). The CODM does not evaluate reportable segment asset or liability information.
21
A summary of financial information by reportable segment is as follows (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| APUS Segment | ||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Instructional costs and services | ||||||||||||||||||||||||||
| Selling and promotional | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
Other (1) | ||||||||||||||||||||||||||
| Income from operations before interest and income taxes | ||||||||||||||||||||||||||
| RU Segment | ||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Instructional costs and services | ||||||||||||||||||||||||||
| Selling and promotional | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
Other (2) | ||||||||||||||||||||||||||
| Loss from operations before interest and income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
| HCN Segment | ||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Instructional costs and services | ||||||||||||||||||||||||||
| Selling and promotional | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
Other (3) | ||||||||||||||||||||||||||
| Loss from operations before interest and income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
| Corporate and Other | ||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Instructional costs and services | ||||||||||||||||||||||||||
| Selling and promotional | ||||||||||||||||||||||||||
| General and administrative | ||||||||||||||||||||||||||
Other (3) | ||||||||||||||||||||||||||
| Loss from operations before interest and income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
| Total reportable segment revenue | ||||||||||||||||||||||||||
| Corporate and other revenue | ||||||||||||||||||||||||||
| Total consolidated revenue | ||||||||||||||||||||||||||
| Total reportable segment income from operations before interest and income taxes | ||||||||||||||||||||||||||
| Corporate and other (loss) from operations before interest and income taxes | ( | ( | ( | ( | ||||||||||||||||||||||
| Total consolidated income from operations before interest and income taxes | ||||||||||||||||||||||||||
(1) Includes loss on assets held for sale, loss on disposal of long-lived assets, and depreciation and amortization expense.
(2) Includes loss on disposal of long-lived assets, loss on leases (in 2024), and depreciation and amortization expense.
(3) Includes depreciation and amortization expense.
22
| Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| (In thousands) | (In thousands) | |||||||||||||||||||||||||
| Depreciation and amortization | ||||||||||||||||||||||||||
| APUS Segment | ||||||||||||||||||||||||||
| RU Segment | ||||||||||||||||||||||||||
| HCN Segment | ||||||||||||||||||||||||||
| Total reportable segment depreciation and amortization | ||||||||||||||||||||||||||
| Corporate and Other | ||||||||||||||||||||||||||
| Total consolidated depreciation and amortization | ||||||||||||||||||||||||||
| Interest expense, net | ||||||||||||||||||||||||||
| APUS Segment | ||||||||||||||||||||||||||
| RU Segment | ( | ( | ||||||||||||||||||||||||
| HCN Segment | ||||||||||||||||||||||||||
| Total reportable segment interest expense, net | ||||||||||||||||||||||||||
| Corporate and Other | ( | ( | ( | ( | ||||||||||||||||||||||
| Total consolidated interest expense, net | ( | ( | ( | ( | ||||||||||||||||||||||
| Income tax expense (benefit) | ||||||||||||||||||||||||||
| APUS Segment | ||||||||||||||||||||||||||
| RU Segment | ( | ( | ( | ( | ||||||||||||||||||||||
| HCN Segment | ( | ( | ( | ( | ||||||||||||||||||||||
| Total reportable segment income tax expense | ||||||||||||||||||||||||||
| Corporate and Other | ( | ( | ( | ( | ||||||||||||||||||||||
| Total consolidated income tax expense | ( | |||||||||||||||||||||||||
Note 10. Contingencies
The Company accrues for costs associated with contingencies, including, but not limited to, regulatory compliance and legal matters, when such costs are probable and can be reasonably estimated. Liabilities established to provide for contingencies are adjusted as further information develops, circumstances change, or contingencies are resolved. The Company bases these accruals on management’s estimate of such costs, which may vary from the ultimate costs and expenses, associated with any such contingency.
From time to time, the Company is involved in legal matters in the normal course of its business.
Note 11. Concentration
The Company’s students utilize various payment sources and programs to finance their education expenses, including funds from: the U.S. Department of Defense, or DoD, tuition assistance programs, or TA; education benefit programs administered by the U.S. Department of Veterans Affairs, or VA; federal student aid from Title IV programs; and cash and other sources.
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| DoD tuition assistance programs | |||||||||||||||||||||||
| VA education benefits | |||||||||||||||||||||||
| Title IV programs | |||||||||||||||||||||||
| Cash and other sources | |||||||||||||||||||||||
A summary of RU Segment revenue derived from students by primary funding source is as follows:
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Title IV programs | |||||||||||||||||||||||
| Cash and other sources | |||||||||||||||||||||||
| VA education benefits | |||||||||||||||||||||||
A summary of HCN Segment revenue derived from students by primary funding source is as follows:
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Title IV programs | |||||||||||||||||||||||
| Cash and other sources | |||||||||||||||||||||||
| VA education benefits | |||||||||||||||||||||||
Note 12. Preferred Stock
On December 28, 2022, APEI issued $40 million of the Series A Senior Preferred Stock, $0.01 par value per share, or Series A Senior Preferred Stock, to affiliates of existing common stockholders of APEI. On June 23, 2025 (the “Redemption Date”), APEI redeemed all 400 outstanding shares of Series A Senior Preferred Stock for $43.1 million, including an early redemption premium of $3.1 million, and excluding $1.4 million in accrued and unpaid dividends. The loss on redemption of $3.5 million was calculated as the difference between the consideration paid, excluding dividends, and the book value of $39.6 million, and was recorded as a reduction to net income available to common stockholders in the accompanying Consolidated Statements of Income for the three months ended June 30, 2025. No shares of preferred stock were issued or outstanding at June 30, 2025. On the Redemption Date, APEI also filed a Certificate of Elimination to its Fifth Amended and Restated Certificate of Incorporation (the “Charter”) with the Secretary of State of the State of Delaware eliminating from the Charter all matters set forth in the Certificate of Designation with respect to the Series A Senior Preferred Stock.
Prior to the Redemption Date, the Series A Senior Preferred Stock had cumulative dividends that accrued daily at the annual rate which was equal to Term (selected by the Company for each divided period), plus 10.00 %, and dividends were paid, after declaration by the Board, for each dividend period. During the three and six months ended June 30, 2024, dividends declared and paid on the Series A Senior Preferred Stock were $1.5 million and $3.0 million, respectively.
As of December 31, 2024, the liquidation preference of $47.0 million was based on the occurrence of a liquidation event, which was also considered an event of default as defined in the Certificate of Designation and included an early redemption premium amount and a make-whole payment. As of December 31, 2024, the make-whole payment included in the liquidation preference was $4.0 million, which was reduced quarterly.
The following table lists the components of the liquidation preference as of December 31, 2024 (in thousands):
| Liquidation Amount | ||||||||
| Series A Senior Preferred Stock (plus accrued and unpaid dividends) | $ | |||||||
| Make whole payment | ||||||||
| Early redemption premium | ||||||||
| Liquidation amount | $ | |||||||
The Series A Senior Preferred Stock had no voting rights for directors or otherwise, except as required by law or with respect to certain protective provisions. Without the consent of at least 60 % of the then outstanding shares of Series A Senior Preferred Stock, with certain exceptions, the Company could not, among other things, (i) incur any indebtedness if such incurrence would cause the Company’s Total Net Leverage Ratio (as defined in the Purchase Agreement) to exceed 0.75 :1, (ii) issue any capital stock senior to or pari passu with the Series A Senior Preferred Stock, (iii) declare or pay any cash dividends on the Company’s common stock, or (iv) repurchase more than an aggregate of $30 million of the Company’s common stock.
Note 13. Subsequent Event
23
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
In this Quarterly Report on Form 10-Q, or Quarterly Report, “we,” “our,” “us,” “the Company” and similar terms refer to American Public Education, Inc., or APEI, and its subsidiary institutions collectively unless the context indicates otherwise. All quarterly information in this Management’s Discussion and Analysis is unaudited. The following discussion of our historical results of operations and our liquidity and capital resources should be read in conjunction with the Consolidated Financial Statements and related notes that appear elsewhere in this Quarterly Report and the audited financial information and related notes, as well as Management’s Discussion and Analysis of Financial Condition and Results of Operations and other disclosures, included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, or our Annual Report.
Forward-Looking Statements
This Quarterly Report contains forward-looking statements intended to be covered by the safe harbor provisions for forward-looking statements in Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. We may use words such as “project,” “believe,” “anticipate,” “plan,” “expect,” “estimate,” “intend,” “should,” “would,” “could,” “potentially,” “will,” or “may,” or other words or expressions that convey future events, conditions, circumstances, or outcomes to identify these forward-looking statements. Forward-looking statements in this Quarterly Report include, without limitation, statements regarding:
•changes in and our efforts and ability to comply with the extensive regulatory framework applicable to our industry, including the 90/10 Rule and financial responsibility standards, as well as state law and regulations and accrediting agency requirements, and the expected impacts of our efforts to comply and any non-compliance;
•actions by the U.S. Department of Education, or ED, institutional and programmatic accreditors, and state authorizing agencies and expectations regarding the effects of those actions;
•our ability to manage, grow, and diversify our business and execute our business initiatives and strategy;
•the impact, timing, projected benefits, and terms of the planned combination of American Public University System, or APUS, Rasmussen University, or RU, and Hondros College of Nursing, or HCN, into one consolidated institution that will be a system encompassing all APUS, RU, and HCN programs, campuses, and operations, or the Combination;
•legislative and regulatory changes, shifts in regulatory priorities, restrictions on the function, operations, and budgets of federal agencies, including ED, as a result of U.S. presidential and administration transitions and presidential directives regarding governmental actions;
•our cash needs and expectations regarding cash flow from operations, including the impacts of our debt service;
•our ability to undertake initiatives to improve the learning experience, attract students who are likely to persist, and improve student outcomes;
•changes to and expectations regarding our student enrollment, net course registrations, and the composition of our student body, including the pace of such changes;
•our ability to maintain, develop, and grow our technology infrastructure to support our student body and remain competitive;
•our conversion of prospective students to enrolled students and our retention of active students;
•our ability to update and expand the content of existing programs and develop new programs to meet emerging student needs and marketplace demands, and our ability to do so in a cost-effective manner or on a timely basis;
•the branding and marketing of our institutions;
•our ability to leverage our investments in support of our initiatives, students, and institutions;
•our maintenance and expansion of our relationships and partnerships and the development of new relationships and partnerships;
•actions by the Department of Defense, or DoD, or branches of the U.S. Armed Forces, including actions related to the participating in DoD tuition assistance, or TA, programs, our responses to those actions, and expectations regarding the effects of those actions and responses;
•federal appropriations and other budgetary matters, including government shutdowns;
•changes in enrollment in postsecondary degree-granting institutions and workforce needs;
•our ability to recognize the intended benefits of our cost savings and revenue-generating efforts;
•the expected impact on our students and our business from campus closures and consolidations;
•our financial performance generally; and
•our expectations and estimates regarding tax and accounting matters.
Forward-looking statements are based on our beliefs, assumptions, and expectations of our future performance, taking into account information currently available to us, and are not guarantees of future results. There are a number of important
24
factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements. Risks and uncertainties involved in forward-looking statements include, among others:
•potential changes to the ED’s and other federal government agencies’ structure, policies, priorities, and oversight, including as a result of federal elections and the Trump administration’s stated intention to dismantle ED;
•our dependence on the effectiveness of our ability to attract students who persist in our institutions’ programs;
•our inability to effectively market our programs or expand into new markets;
•the loss of our ability to receive funds under TA programs or the reduction, elimination, or suspension of TA, or continued disruption due to systems used to request TA;
•our inability to maintain enrollments from military students;
•adverse effects of changes our institutions make to improve the student experience and enhance each institutions ability to identify and enroll students who are likely to succeed;
•our failure to successfully adjust to future market demands;
•our failure to comply with regulatory and accrediting agency requirements or to maintain institutional accreditation, the consequences thereof, and risks related to any actions we may take to prevent or correct such failure;
•our failure to meet applicable National Council Licensure Examination, or NCLEX, pass rates and other NCLEX standards, and the consequences thereof;
•our failure to comply with the 90/10 Rule;
•our loss of eligibility to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs, or ability to process Title IV financial aid;
•our inability to recognize the benefits of our cost savings efforts;
•economic and market conditions in the United States and abroad and changes in interest rates;
•risks related to business combinations, acquisitions, divestitures, and other strategic transactions, including, as applicable, integration challenges, business disruption, dilution of stockholder value, financial charges, and diversion of management attention;
•risks related to our substantial indebtedness; and
•our dependence on and need to continue to invest in our technology infrastructure.
Forward-looking statements should be considered in light of these factors and the factors described elsewhere in this Quarterly Report, including in the “Risk Factors” section of our Annual Report, and in our various filings with the Securities and Exchange Commission, or the SEC. It is important that you read these factors and the other cautionary statements made in this Quarterly Report as being applicable to all related forward-looking statements wherever they appear in this Quarterly Report. If any of these factors materialize, or if any underlying assumptions prove incorrect, our actual results, performance, or achievements may differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. You should also read the more detailed description of our business in our Annual Report when considering forward-looking statements. We caution readers not to place undue reliance on any forward-looking statements herein, which speak only as of the date of this Quarterly Report. We undertake no obligation to publicly update any forward-looking statements after the date of this Quarterly Report, whether as a result of new information, future events, or otherwise, except as required by law.
Overview
Background
We are a provider of online and campus-based postsecondary education to approximately 106,800 students and career learning to approximately 17,000 individuals, through four subsidiary institutions, American Public University System, or APUS, Rasmussen University, or RU, Hondros College of Nursing, or HCN, and Graduate School USA, or GSUSA. Our subsidiary institutions offer purpose-built education programs and career learning designed to prepare individuals for productive contributions to their professions and society, and to offer opportunities designed to advance students in their current professions or to help them prepare for their next career. Our subsidiary institutions are licensed or otherwise authorized by state authorities to offer postsecondary education programs to the extent the institutions believe such licenses or authorizations are required, and APUS, RU, and HCN are certified by ED to participate in Title IV programs.
Our Institutions
Our wholly owned operating subsidiary institutions include the following:
•American Public University System, Inc., referred to herein as APUS, provides online postsecondary education to approximately 88,500 adult learners, directed primarily at the needs of the military, veterans, extended military
25
families, and other public service and service-minded communities through two brands: American Military University, or AMU, and American Public University, or APU. As of June 30, 2025, approximately 64% of APUS students self-reported that they served in the military on active duty at the time of initial enrollment.
•Rasmussen College, LLC, referred to herein as Rasmussen University, or RU, provides nursing- and health sciences-focused postsecondary education to approximately 14,600 students at 20 campuses in six states and online. As of June 30, 2025, on-ground enrollment was 6,400, of which approximately 5,700 students were pursuing nursing degrees at RU, approximately 90% of whom were enrolled in RU’s pre-licensure nursing degree programs. At June 30, 2025, online enrollment was approximately 8,200 students.
•National Education Seminars, Inc., referred to herein as Hondros College of Nursing, or HCN, provides nursing education to approximately 3,700 students at eight campuses in three states. HCN’s students are enrolled in its pre-licensure nursing degree programs or its Medical Assisting Diploma program.
•American Public Training LLC, referred to herein as Graduate School USA, or GSUSA, provides career learning and leadership training in-person and online to the federal workforce. GSUSA operational activities are presented within Corporate and Other. In July 2025, APEI entered into a definitive agreement to sell all its membership interest in GSUSA, and the sale was completed on July 25, 2025.
The Planned Combination of APUS, RU, and HCN
On January 28, 2025, we announced the planned combination of APUS, RU, and HCN, or the Combination, which will result in a combined institution named American Public University System comprised of two divisions tentatively named (i) APUS Global, comprised of AMU and APU, and (ii) Rasmussen, comprised of RU’s campus-based and online nursing programs, RU’s healthcare programs, HCN’s campus-based nursing and healthcare programs, and RU’s non-healthcare programs, with final division names to be determined closer to closing of the Combination. The Combination constitutes a Change of Control, Structure or Organization pursuant to HLC policy and, accordingly, we needed to receive HLC approval prior to effectuating the Combination. APUS and RU jointly submitted an application for Change of Control, Structure or Organization. For HLC purposes, APUS will be the surviving institution, and the application sought approval for the Combination and the expansion of APUS’s HLC accreditation to include the RU and HCN programs and locations. HLC conducted a site visit in March 2025 related to the joint application. At its June 2025 meeting, HLC approved the Combination and continuation of accreditation upon implementation of the related transactions. We continue to engage with ED and HLC as to their preferred implementation process and timing for the Combination. As previously disclosed, we had anticipated completing the Combination in the third quarter of 2025 subject to obtaining required approvals and ED taking related actions. However, as a result of our ongoing dialogue with ED and HLC, we may seek to postpone implementation of the Combination, which could extend into the second quarter of 2026.
Legislative and Regulatory Activity
The One Big Beautiful Bill Act
On July 4, 2025, the One Big Beautiful Bill Act, or the OBBBA, was signed into law. Among other things, the OBBBA amends portions of the Higher Education Act of 1965, as amended, makes changes to the Title IV programs, and restores certain ED regulations related to borrower defense to repayment and closed school discharge.
The OBBBA will overhaul the structure of certain student loan programs. Effective July 1, 2026, it will eliminate Federal Direct PLUS loans for graduate and professional students, with limited grandfathering. The law also: fixes annual and aggregate loan limits for graduate students, with different caps depending on whether they are or have been professional students; creates a lifetime maximum aggregate amount for Title IV loans (other than a loan made to the student as a parent on behalf of a dependent); authorizes institutions to limit the amount of loans a student may borrow in an academic year provided such limit is applied consistently to all students enrolled in a program; and requires the amount of loan funds available under a student’s annual loan eligibility to be reduced proportionately to the degree to which that student is not enrolled on a full-time basis.
The OBBBA also establishes an accountability framework, effective July 1, 2026, that institutions must satisfy at the program level in order for students in the program to continue to receive Federal Direct Loans, requiring that an undergraduate or graduate or professional program be ineligible for Federal Direct Loans if, in two out of three consecutive years, the median earnings of a cohort of program completers are less than the median earnings of working adults aged 25-34 with only a high school diploma or a bachelor’s degree, respectively, either in the state where the institution is located or, if fewer than 50% of
26
students at the institution reside in the institution’s state, the national average. If a program fails the earnings test for one year, institutions must notify students that the program is at risk of losing Federal Direct Loan eligibility.
The OBBBA creates Workforce Pell Grants, effective July 1, 2026, for students enrolled in eligible workforce programs that satisfy certain requirements and limits eligibility for Pell Grants in certain ways.
The OBBBA also changes existing U.S. tax laws, including extending or making permanent certain provisions of the Tax Cuts and Jobs Act, repealing certain clean energy initiatives, in addition to other changes. The Company anticipates the changes in tax laws will not have a material impact to deferred tax assets and liabilities, and to income taxes payable in the period of enactment. The Company continues to evaluate the impact the new legislation will have on the Consolidated Financial Statements.
In September 2019, ED published modifications to its financial responsibility standards that took effect July 1, 2020, or the 2019 Borrower Defense Regulations. The 2019 Borrower Defense Regulations modified ED’s requirements with respect to the circumstances under which a borrower is eligible for a loan discharge if an institution or location closes. The OBBBA reinstates the 2019 Borrower Defense Regulations, and the closed loan discharge regulations that were in effect on June 30, 2023. On November 1, 2022, ED published final regulations with an effective date of July 1, 2023, to address borrower defense to repayment, closed school loan discharge, pre-dispute arbitration and class-action waivers, among other issues, or the 2022 Borrower Defense Regulations. The OBBBA also resets the effective date of the 2022 Borrower Defense Regulations, including the closed school loan discharge provisions, for July 1, 2035.
American Public University System
APUS participates in the Department of Defense, or DoD, tuition assistance, or TA, programs, and is required to sign a Memorandum of Understanding, or MOU, outlining certain commitments and agreements between the institution and DoD as a condition to participate in TA. In February 2025, ICP notified APUS that it will conduct a review of APUS compliance with the DoD MOU. On May 14, 2025, DoD issued a report that informed APUS that the review had been completed with no findings.
Rasmussen University
The Florida legislature passed legislation in May 2025 that would have subjected RU nursing programs to additional regulatory scrutiny by the Florida Board of Nursing and the Florida Department of Health. The legislation was vetoed by the governor on July 2, 2025.
In May 2025, ED released RU from the temporary growth restrictions, imposed in connection with RU’s 2019 change in ownership, which preceded our acquisition of RU, that restricted RU from adding new programs and locations. The timing of the Combination could, however, delay our ability to seek approval from the HLC of new locations or programs.
RU’s Moorhead, Minnesota Associate of Science Professional Nursing, or ADN program, and Practical Nursing Diploma, or PN program, which together contributed approximately 1% of RU’s quarterly revenue, are currently approved by Minnesota Board of Nursing, or MBN, but first-time NCLEX pass rates for each of these programs have been below the required standard for three consecutive years. In August 2024, MBN placed RU’s Moorhead, Minnesota PN program on conditional approval status and issued a corrective action order. The PN program’s NCLEX pass rate was required to meet the state standard by the end of June 2025, measured using cumulative pass rates from the preceding four quarters (i.e., July 2024 to June 2025). The program met the standard and is awaiting the Board’s action at its August 2025 meeting. In June 2025, the MBN issued a stipulation and consent order with RU’s Moorhead, Minnesota ADN program to, among other things, meet applicable NCLEX pass rate standards by the end of 2025 for new candidates taking the licensing exam for the first time. If compliance is not achieved by December 31, 2025, the program will be given until June 30, 2026, to meet the required NCLEX pass rates based on the cumulative results from the first and second calendar quarters of 2026 for candidates, and, if not achieved, MBN may withdrawal program approval.
Hondros College of Nursing
As a requirement for accreditation, ABHES requires institutions to demonstrate at least a 70% retention rate for each program. For institutions not meeting the retention standard, ABHES may provide an opportunity for a program to come into compliance within a specified time period, and may extend such period if a program demonstrates improvement or for other good cause. For the reporting year ended June 30, 2024, HCN’s Cleveland and Dayton PN programs, and the Akron ADN program were below the 70% benchmark for retention. As a result, ABHES placed the Cleveland and Dayton PN programs and Akron ADN program on outcomes reporting status and required HCN to submit reports for each of these programs
27
demonstrating their retention rate met the standard through the first three quarters of the 2024-2025 reporting year by May 2025. These three programs met the 70% benchmark for the reporting period, and, as a result, at its July 2025 meeting, the ABHES Commission voted to remove retention reporting requirements.
Graduate School USA
GSUSA provides contract training to federal government agency customers and through direct enrollment by federal, state, and municipal government employees, contractors, and non-government employees. On July 10, 2025, APEI entered into a definitive agreement to sell all of its membership interest in GSUSA for $0.5 million, subject to customary adjustments, including for net working capital and cash. The sale was completed on July 25, 2025, and is expected to result in a loss on sale between $7.0 million and $8.5 million, subject to post-close adjustments for working capital and cash.
Department of Education
On July 7, 2025, ED issued an interpretative rule that revised a prior interpretation and clarified ED’s classification of revenue received by for-profit schools under the 90/10 Rule under which a for-profit institution is prohibited from deriving more than 90% of its revenue (as computed by ED) on a cash accounting basis from federal funds for any fiscal year. The interpretive rule specifies that for-profit schools will be allowed to count non-federal funds generated from programs offered entirely through distance education, if such programs satisfy certain criteria, as non-federal revenue in their 90/10 calculations, and may revise 90/10 Rule calculations for prior fiscal years to include revenue from distance education programs in the “10%” side of the ratio.
Tuition Increases
Providing affordable degree and certificate programs is an important element of our competitive strategy. In April 2024, APUS implemented a tuition increase to master’s level students across all categories, including military, non-military and veteran students, and in September 2024, APUS returned the military rate for master’s level students to the $250 per credit hour rate in effect prior to the April 2024 tuition increase. We believe that APUS’s tuition and fees remain lower than the average in-state cost at public universities. RU implemented modest tuition increases for all students in select programs in the first quarter of 2024, for new students in select programs in August 2024, and for returning students in select programs in October 2024. RU plans to implement modest tuition increases for new and reentering students in August 2025, for current students in non-prelicensure nursing programs in October 2025, and for prelicensure nursing program students in January 2026. HCN plans to implement a 5% increase in tuition and fees effective in the fourth quarter of 2025, for its ADN and PN programs. The tuition and fee increases at RU and HCN are intended to reflect adjustments to be consistent with the local campus markets. Even with these increases, RU and HCN’s tuition and fees are designed to be affordable and competitive when compared to the tuition and fees at similar institutions offering the same level of flexibility, accessibility, and student experience.
Campus Closures
During the six months ended June 30, 2024, our RU Segment consolidated two Minnesota campuses, and in May 2024, RU notified the Wisconsin Educational Approval Program, or EAP, that it intends to voluntarily close its two Wisconsin campuses, effective December 31, 2025, and 2026, respectively. All students enrolled at the two Wisconsin campuses have expected graduation dates on or before the applicable campus closing date. These actions are expected to directly impact approximately 30 students, or less than 1% of RU’s current total enrollment.
Reportable Segments
Our operations are organized into three reportable segments:
•American Public University System Segment, or APUS Segment. This segment reflects the operational activities of APUS.
•Rasmussen University Segment, or RU Segment. This segment reflects the operational activities of RU.
•Hondros College of Nursing Segment, or HCN Segment. This segment reflects the operational activities of HCN.
Adjustments to reconcile segment results to the Consolidated Financial Statements are included in Corporate and Other. These adjustments include unallocated corporate activity and eliminations, and the operational activities of GSUSA.
28
Summary of Results
Consolidated revenue for the three months ended June 30, 2025, increased to $162.8 million from $152.9 million, or by 6.5%, as compared to the prior year period. Our net income for the three months ended June 30, 2025, was $4.5 million, compared to $0.4 million in the prior year period, an increase of $4.1 million. The results for the three months ended June 30, 2025, include $1.7 million in pre-tax professional fees in Corporate and Other relating to the Combination and the sale of GSUSA. The results in the prior year period include a $1.1 million non-cash loss on sale of an equity investment in Corporate and Other, a $0.8 million pre-tax non-cash loss on leases in our RU Segment, $0.5 million in pre-tax severance costs related to the former president of GSUSA in Corporate and Other and the planned closure of the Wisconsin campuses in our RU Segment, and $0.2 million in pre-tax information technology transition service costs in our APUS and HCN Segments, as well as Corporate and Other. Our operating margin improved to 4.3% for the three months ended June 30, 2025, as compared to 1.5% in the prior year period. Excluding the professional fees relating to the Combination in 2025 and the sale of GSUSA, the loss on leases, severance costs and information technology transition service costs in 2024, our operating margin was 5.4% and 2.4% for the three months ended June 30, 2025, and 2024, respectively.
Consolidated revenue for the six months ended June 30, 2024, increased to $327.3 million from $307.3 million, or by 6.5%, as compared to the prior year period. Our net income for the six months ended June 30, 2024, was $13.4 million, compared to $0.9 million in the prior year period, an increase of $12.5 million. The results for the three months ended June 30, 2025, include $2.7 million in professional fees in Corporate and Other relating to the Combination and the sale of GSUSA, and a non-cash $1.5 million loss on assets held for sale in our APUS Segment, both on a pre-tax basis. The results for the six months ended June 30, 2024, include non-cash losses on investments of $4.4 million in Corporate and Other, a $3.7 million pre-tax loss on leases in our RU Segment, $2.0 million in pre-tax information technology transition service costs in our APUS and HCN Segments as well as Corporate and Other, and $0.5 million in pre-tax severance costs related to the former president of GSUSA in Corporate and Other and the planned closure of the Wisconsin campuses in our RU Segment. Our operating margin improved to 5.9% for the six months ended June 30, 2025, compared to 2.4%, in the prior year period. Excluding the loss on assets held for sale and professional fees relating to the Combination in 2025 and the sale of GSUSA, and the loss on leases, information technology transition service costs and severance costs in 2024, our operating margin was 7.2% for the six months ended June 30, 2025, compared to 4.4% for the six months ended June 30, 2024.
APUS net course registrations for the three months ended June 30, 2025, increased to approximately 96,400 from approximately 89,800, an increase of 6,600, or 7.3%, as compared to the prior year period. APUS Segment revenue for the three months ended June 30, 2025, increased to $81.7 million from $77.0 million, or by 6.1%, as compared to the prior year period. The revenue increase for the period was less than the increase in net course registrations due the timing of course starts within the respective periods. APUS net course registrations for the six months ended June 30, 2025, increased to approximately 198,900 from approximately 188,800, an increase of 10,100, or 5.3%, as compared to the prior year period. APUS Segment revenue for the six months ended June 30, 2025, increased to $165.7 million from $157.7 million, or by 5.1%, as compared to the prior year period. APUS Segment operating margin increased to 26.2% for the three months ended June 30, 2025, from 23.7% in the prior year period, and increased to 27.5% for the six months ended June 30, 2025, from 26.2% in the prior year period.
RU total enrollment for the three months ended June 30, 2025, increased to approximately 14,600 from approximately 13,600, an increase of 1,000, or 7.4%, as compared to the prior year period. RU Segment revenue for the three months ended June 30, 2025, increased to $59.5 million from $53.0 million, or by 12.2%, as compared to the prior year period. RU total enrollment for the six months ended June 30, 2025, increased approximately 7.4%, as compared to the prior year period. RU Segment revenue for the six months ended June 30, 2025, increased to $118.8 million from $106.2 million, or by 11.9%, as compared to the prior year period. The revenue increases for the three and six month periods were greater than the enrollment increases for the comparable prior year periods due to tuition increases in the second half of 2024. RU Segment operating margin improved to negative 3.3% for the three months ended June 30, 2025, from negative 16.6% in the prior year period, and improved to negative 1.7% for the six months ended June 30, 2025, from negative 16.8% in the prior year period.
HCN total enrollment for the three months ended June 30, 2025, increased to approximately 3,700 from approximately 3,300, an increase of 400, or 13.5%, as compared to the prior year period. HCN Segment revenue for the three months ended June 30, 2025, increased to $18.1 million from $16.4 million, or by 10.5%, as compared to the prior year period. HCN total enrollment for the six months ended June 30, 2025, increased approximately 11.5%, as compared to the prior year period. HCN Segment revenue for the six months ended June 30, 2025, increased to $35.8 million from $32.9 million, or by 9.0%, as compared to the prior year period. The revenue increase for the three and six month periods were less than the enrollment increase due to the change in course load mix, and higher student enrollment from community partners which is at a lower revenue per student. HCN Segment operating margin improved to negative 2.2% for the three months ended June 30, 2025, from negative 4.5% in the prior year period, and remained unchanged at negative 3.2% for both the six month periods ended June 30, 2025 and 2024.
29
Critical Accounting Estimates
Goodwill and indefinite-lived intangible assets. Goodwill is the excess of the purchase price of an acquired business over the fair value of the assets acquired and liabilities assumed, and the fair value assigned to identifiable intangible assets. Goodwill is not amortized. Goodwill is reported at the reporting unit level that we have defined as our reporting segments. In connection with our acquisitions of RU and HCN, we recorded $217.4 million and $38.6 million of goodwill, respectively, in our RU and HCN Segments. We later recorded non-cash impairment charges reducing the carrying value of RU and HCN Segment goodwill to $33.0 million and $26.6 million, respectively. There was no goodwill recorded in connection with the acquisition of GSUSA. No goodwill is recorded in our APUS Segment.
In addition to goodwill, in connection with the acquisitions of RU and HCN, we recorded identified intangible assets with an indefinite useful life in the aggregate amount of $51.0 million and $3.7 million, respectively, in our RU and HCN Segments, which included intangible assets related to trade name, accreditation, licensing, and Title IV, and affiliate agreements. We later recorded non-cash impairment charges reducing the carrying value of RU indefinite-lived identified intangible assets to $24.5 million. There were no indefinite useful life intangible assets identified as a result of the acquisition of GSUSA. There are no indefinite-lived intangible assets in our APUS Segment.
We recorded $35.5 million, $4.4 million, and $1.0 million of identified intangible assets with a definite useful life in connection with the acquisitions of RU, HCN, and GSUSA, respectively. There are no definite-lived intangible assets in our APUS Segment.
Goodwill and indefinite-lived intangible assets are tested for impairment at least annually, and more frequently if events or changes in circumstances exist that would more likely than not reduce the fair value of the reporting unit below its carrying amount. The process of evaluating goodwill and indefinite-lived intangible assets for impairment is subjective and requires significant judgment and estimates. Impairment testing consists of an optional qualitative assessment as well as a quantitative test. When performing a qualitative assessment, we consider many factors, including general economic conditions, industry and market conditions, certain cost factors, financial performance and key business drivers (for example, student enrollment), long-term operating plans, and potential changes to significant assumptions and estimates used in the most recent fair value analysis. Unanticipated events and circumstances may occur that may affect the accuracy or validity of such assumptions and estimates. Actual results may differ and have a material impact or our results of operations and financial position, and subsequent events are not necessarily indicative of the reasonableness of the original assumptions or estimates.
We estimate fair value in our quantitative analysis by weighting the results from two different valuation approaches. They are: (1) discounted cash flow and (2) guideline public company. Under the discounted cash flow method, fair value is determined by discounting the estimated future cash flows of RU and HCN at their estimated weighted-average cost of capital. We incorporate the use of projected financial information and a discount rate that are developed using market participant-based assumptions. The cash-flow projections are based on three-year financial forecasts developed by management that include revenue projections, capital spending trends, and investment in working capital to support anticipated revenue growth, which are updated at least annually and approved by management. Under the guideline public company method, pricing multiples from other public companies in the public higher education market are used to determine the fair value of RU and HCN. Values derived under the two valuation methods are then weighted to estimate RU and HCN’s enterprise values. If we determine that the carrying amount of a reporting unit exceeds its fair value, we then calculate the implied fair value of the reporting unit goodwill as compared to its carrying amount to determine the appropriate impairment charge. Although we believe our assumptions are reasonable, actual results may vary significantly and may expose us to material impairment charges in the future. Our methodology for determining fair values remained consistent for the periods presented.
During the three months ended June 30, 2025, we completed a qualitative assessment for potential impairment of the RU and HCN Segment goodwill and indefinite-lived intangible assets. As part of the assessment, we considered the events and circumstances expressly required by ASC 350, in addition to other entity-specific factors. Factors considered included RU and HCN’s financial and enrollment performance against internal targets, economic factors, and the continued favorable growth outlook for nursing education. After completing this qualitative assessment, we concluded it was more likely than not that the fair value of each of the RU and HCN Segments was greater than the respective carrying value, and therefore no quantitative impairment test and no impairment charge was necessary.
Significant assumptions inherent to valuation methodologies for goodwill include, but are not limited to, prospective financial information, growth rates, terminal value, discount rates, and comparable multiples from publicly traded companies in the higher education market. Future changes, including minor changes in the significant assumption or other factors including
30
revenue, operating income, valuation multiples, and other inputs to the valuation process may result in future impairment charges, and those charges could be material.
For more information regarding our Critical Accounting Policies and Use of Estimates, see the “Critical Accounting Policies and Estimates” section of “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report.
Results of Operations
Below we have included a discussion of our operating results and material changes in our operating results during the three and six months ended June 30, 2025, compared to the three and six months ended June 30, 2024. Our revenue and operating results normally fluctuate as a result of seasonal or other variations in our enrollments and the level of expenses in our reportable segments. Our student population varies as a result of new enrollments, graduations, student attrition, the success of our marketing programs, and other reasons that we cannot always anticipate. We expect quarterly fluctuations in operating results to continue as a result of various enrollment patterns and changes in revenue and expenses.
APUS net course registrations for the three months ended June 30, 2025, increased to approximately 96,400 from approximately 89,800, an increase of 6,600, or 7.3%, as compared to the prior year period. APUS net course registrations for the six months ended June 30, 2025, increased to approximately 198,900 from approximately 188,800, an increase of 10,100, or 5.3%, as compared to the prior year period primarily due to an increase in registrations by students utilizing federal student aid and military-affiliated students utilizing education benefit programs administered by the U.S. Department of Veterans Affairs, or VA. APUS Segment operating margin increased to 26.2% for the three months ended June 30, 2025, from 23.7% in the prior year period and increased to 27.5% from 26.2% for the six months ended June 30, 2025, as compared to the prior year period. The increase in operating margin for the three months ended June 30, 2025, was primarily due to the increase in revenue and a decrease in information technology costs, partially offset by an increase in employee compensation costs, as compared to the prior year period. The increase in operating margin for the six months ended June 30, 2025, was primarily due to an increase in revenue and a decrease in professional fees, partially offset by the increase in employee compensation costs and the loss on assets held for sale, as compared to the prior year period.
RU total enrollment for the three months ended June 30, 2025, increased to approximately 14,600 from approximately 13,600, an increase of 1,000, or 7.4%, as compared to the prior year period, driven by a 12.2% increase in online enrollment and a 3.2% increase in on-ground enrollment. RU total enrollment for the six months ended June 30, 2025, increased approximately 7.4%, as compared to the prior year period, driven by an 11.6% increase in online enrollment and a 3.2% increase in on-ground enrollment. RU Segment operating margin improved to negative 3.3% for the three months ended June 30, 2025, from negative 16.6%, in the prior year period. The improvement in the operating margin for the three months ended June 30, 2025, was primarily due to the increase in revenue as well as decreases in information technology costs, depreciation and amortization expenses, loss on leases, and occupancy costs, partially offset by an increase in employee compensation costs and classroom and materials costs, as compared to the prior year period. RU Segment operating margin improved to negative 1.7% for the six months ended June 30, 2025, from negative 16.8% in the prior year period. The improvement in the operating margin for the six months ended June 30, 2025, was primarily due to the increase in revenue as well as decreases in loss on leases, information technology costs, depreciation and amortization expenses, occupancy costs, and advertising costs, partially offset by an increase in employee compensation costs, as compared to the prior year period.
HCN total enrollment for the three months ended June 30, 2025, increased to approximately 3,700 from approximately 3,300, an increase of 400, or 13.5%, as compared to the prior year period. HCN total enrollment for the six months ended June 30, 2025, increased approximately 11.5%, as compared to the prior year period. HCN Segment operating margin improved to negative 2.2% for the three months ended June 30, 2025, from negative 4.5% in the prior year period, and remained unchanged at negative 3.2% for both the six month periods ended June 30, 2025 and 2024. The improvement in the operating margin for the three months ended June 30, 2025, was primarily due to the increase in revenue as well as a decrease in occupancy costs, partially offset by increases in employee compensation costs, classroom and course materials costs, and bad debt expense, as compared to the prior year period.
For a more detailed discussion of our results by reportable segment, refer to “Analysis of Operating Results by Reportable Segment” below.
31
Analysis of Consolidated Statements of Income
The following table sets forth statements of income data as a percentage of revenue for each of the periods indicated:
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| Revenue | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Instructional costs and services | 48.2 | 49.8 | 46.9 | 48.4 | |||||||||||||||||||
| Selling and promotional | 21.5 | 22.1 | 21.5 | 21.6 | |||||||||||||||||||
| General and administrative | 23.4 | 22.5 | 22.8 | 23.0 | |||||||||||||||||||
| Depreciation and amortization | 2.5 | 3.4 | 2.5 | 3.4 | |||||||||||||||||||
| Loss on assets held for sale | — | — | 0.5 | — | |||||||||||||||||||
| Loss on leases | — | 0.5 | — | 1.2 | |||||||||||||||||||
| Loss on disposals of long-lived assets | — | 0.1 | — | 0.1 | |||||||||||||||||||
| Total costs and expenses | 95.7 | 98.5 | 94.1 | 97.6 | |||||||||||||||||||
| Income from operations before interest and income taxes | 4.3 | 1.5 | 5.9 | 2.4 | |||||||||||||||||||
| Interest expense, net | (0.7) | (0.5) | (0.6) | (0.3) | |||||||||||||||||||
| Income from operations before income taxes | 3.6 | 0.9 | 5.3 | 2.1 | |||||||||||||||||||
| Income tax expense | 0.9 | — | 1.2 | 0.4 | |||||||||||||||||||
| Equity investment loss | — | (0.7) | — | (1.4) | |||||||||||||||||||
| Net income | 2.8 | 0.2 | 4.1 | 0.3 | |||||||||||||||||||
| Preferred stock dividend | 0.8 | 1.0 | 0.8 | 1.0 | |||||||||||||||||||
| Loss on redemption of preferred stock | 2.2 | — | 1.1 | — | |||||||||||||||||||
| Net (loss) income available to common shareholders | (0.2) | % | (0.8) | % | 2.2 | % | (0.7) | % | |||||||||||||||
Three Months Ended June 30, 2025, Compared to Three Months Ended June 30, 2024
Revenue. Our consolidated revenue for the three months ended June 30, 2025, was $162.8 million, an increase of $9.9 million, or 6.5%, compared to $152.9 million for the three months ended June 30, 2024. The increase in revenue was primarily due to a $6.5 million, or 12.2%, increase in revenue in our RU Segment, a $4.7 million, or 6.1%, increase in revenue in our APUS Segment, and a $1.7 million, or 10.5%, increase in revenue in our HCN Segment, partially offset by a $3.1 million, or 47.5%, decrease in GSUSA revenue included in Corporate and Other. The RU Segment revenue increase was primarily due to a 7.4% increase in total student enrollment and the impact of tuition increases in 2024. The APUS Segment revenue increase was primarily due to a 7.3% increase in net course registrations, as compared to the prior year period. The HCN Segment revenue increase was primarily due to a 13.5% increase in total student enrollment, as compared to the prior year period.
Costs and expenses. Costs and expenses for the three months ended June 30, 2025, were $155.7 million, an increase of $5.1 million, or 3.4%, compared to $150.7 million for the three months ended June 30, 2024. Costs and expenses for the three months ended June 30, 2025, included $1.7 million in pre-tax professional fees in Corporate and Other relating to the Combination and the sale of GSUSA. Costs and expenses in the prior year period included a $0.8 million loss on leases in our RU Segment, $0.5 million in severance costs related to the former president of GSUSA in Corporate and Other and the planned closure of the Wisconsin campuses in our RU Segment, and $0.2 million in information technology transition service costs in our APUS and HCN Segments as well as Corporate and Other, all on a pre-tax basis. Costs and expenses for the three months ended June 30, 2025, as compared to the prior year period, excluding the items noted above, increased $4.8 million, or 3.2%, due primarily to increases in employee compensation costs, professional fees, and classroom and course materials costs, partially offset by decreases in information technology costs, depreciation and amortization expenses, and occupancy costs. Costs and expenses as a percentage of revenue decreased to 95.7% for the three months ended June 30, 2025, from 98.5% for the three months ended June 30, 2024.
Instructional costs and services expenses. Our instructional costs and services expenses for the three months ended June 30, 2025, were $78.4 million, an increase of $2.2 million, or 2.9%, compared to $76.2 million for the three months ended June 30, 2024. The increase in instructional costs and services expenses was primarily due to increases in faculty compensation costs in our RU, APUS, and HCN Segments due to an increase in registrations at APUS and enrollments at RU and HCN, and an
32
increase in classroom and course materials costs in our RU and HCN Segments, partially offset by decreases information technology costs in our RU Segment and occupancy costs in our RU and HCN Segments. Instructional costs and services expenses as a percentage of revenue decreased to 48.2% for the three months ended June 30, 2025, from 49.8% for the three months ended June 30, 2024.
Selling and promotional expenses. Our selling and promotional expenses for the three months ended June 30, 2025, were $35.0 million, an increase of $1.2 million, or 3.6%, compared to $33.8 million for the three months ended June 30, 2024. The increase in selling and promotional expenses was primarily due to increases in employee compensation costs in all our segments, and an increase in advertising costs in our APUS and HCN Segments, partially offset by a decrease in advertising costs in our RU Segment. Selling and promotional expenses as a percentage of revenue decreased to 21.5% for the three months ended June 30, 2025, from 22.1% for the three months ended June 30, 2024.
General and administrative expenses. Our general and administrative expenses for the three months ended June 30, 2025, were $38.1 million, an increase of $3.7 million, or 10.8%, compared to $34.4 million for the three months ended June 30, 2024. For the three months ended June 30, 2025, general and administrative expenses included $1.7 million in pre-tax professional fees relating to the Combination in Corporate and Other and the sale of GSUSA. General and administrative expenses in the prior year period included $0.5 million in severance costs related to the former president of GSUSA in Corporate and Other and the planned closure of the Wisconsin campuses in our RU Segment, and $0.2 million in information technology transition service costs in our APUS and HCN Segments as well as Corporate and Other, both on a pre-tax basis. The increase in general and administrative expenses is primarily due to increases in employee compensation costs in Corporate and Other and our APUS Segment, and an increase in professional fees in Corporate and Other, partially offset by decreases in information technology costs in Corporate and Other and our APUS and RU Segments. Consolidated bad debt expense for the three months ended June 30, 2025, was $4.8 million, or 3.0% of revenue, compared to $4.3 million, or 2.8% of revenue in the prior year period. General and administrative expenses as a percentage of revenue increased to 23.4% for the three months ended June 30, 2025, from 22.5% for the three months ended June 30, 2024. As we continue to evaluate enhancements to our business capabilities, we may incur additional costs and that our general and administrative expenses will vary from time to time.
Depreciation and amortization expenses. Depreciation and amortization expenses were $4.1 million for three months ended June 30, 2025, compared to $5.2 million in the prior year period, a decrease of $1.1 million, primarily related to the full amortization of all definite lived intangible assets in our RU Segment in 2024. Depreciation and amortization expenses as a percentage of revenue was 2.5% and 3.4% for the three months ended June 30, 2025, and 2024, respectively.
Loss on disposals of long-lived assets. The loss on disposal of long-lived assets was $35,000 for the three months ended June 30, 2025, as compared to $184,000 for the three months ended June 30, 2024.
Stock-based compensation expenses. Stock-based compensation expenses included in instructional costs and services, selling and promotional, and general and administrative expenses were $2.2 million and $1.8 million for the three months ended June 30, 2025, and 2024, respectively. Stock-based compensation costs included accelerated expense for retirement-eligible employees and performance stock unit incentive costs.
Interest expense, net. Interest expense, net of interest and other income, was $1.1 million and $0.8 million for the three months ended June 30, 2025, and 2024, respectively. The increase in net interest expense in the three months ended June 30, 2025, as compared to the prior year period, was primarily due to an increase in interest expense due to the expiration of the interest rate cap in December 2024, and a decrease in interest income earned.
Income tax expense (benefit). We recognized income tax expense of $1.4 million compared to a tax benefit $16,000 for the three months ended June 30, 2025, and 2024, respectively, or an effective tax rate of 24.0% in 2025, and negative 4.5% 2024. The effective tax rate in 2024 is primarily due to non-deductible stock compensation, partially offset by the $1.1 million equity investment loss not deductible for tax purposes.
Equity investment loss. There was no equity investment loss for the three months ended June 30, 2025. The $1.1 million equity investment loss in the three months ended June 30, 2024, was related to the sale of our remaining equity method investment.
Net income. Our net income was $4.5 million and $0.4 million for the three months ended June 30, 2025, and 2024, respectively, an increase of $4.1 million. This increase was related to the factors discussed above.
Preferred stock dividends. Preferred stock dividends were $1.3 million and $1.5 million for the three months ended June 30, 2025, and 2024, respectively.
33
Loss on redemption of preferred stock. In June 2025, we redeemed all outstanding shares of our Series A Senior Preferred Stock for $43.1 million, excluding unpaid and accrued dividends of $1.4 million, resulting in a loss of $3.5 million related to the redemption premium and fees.
Net loss available to common stockholders. The net loss available to common stockholders was $0.3 million for the three months ended June 30, 2025, compared to a net loss available to common stockholders of $1.2 million for the three months ended June 30, 2024, an improvement of $0.8 million. This improvement was related to the factors discussed above.
Six Months Ended June 30, 2025, Compared to Six Months Ended June 30, 2024
Revenue. Our consolidated revenue for the six months ended June 30, 2025, was $327.3 million, an increase of $20.0 million, or 6.5%, compared to $307.3 million for the six months ended June 30, 2024. The increase in revenue was primarily due to a $12.6 million, or 11.9%, increase in revenue in our RU Segment, an $8.0 million, or 5.1% increase in revenue in our APUS Segment, and a $3.0 million, or 9.0%, increase in revenue in our HCN Segment, partially offset by a $3.6 million, or 33.6%, decrease in GSUSA revenue included in Corporate and Other. The RU Segment revenue increase, as compared to the prior year period, was primarily due to a 7.4% increase in total student enrollment and the impact of tuition increases in 2024. The APUS Segment revenue increase was primarily due to a 5.3% increase in net course registrations, as compared to the prior year period. The HCN Segment revenue increase was primarily due to an 11.5% increase in total student enrollment.
Costs and expenses. Costs and expenses for the six months ended June 30, 2025, were $308.0 million, an increase of $8.1 million, or 2.7%, compared to $299.9 million for the six months ended June 30, 2024. Costs and expenses for the six months ended June 30, 2025, included $2.7 million in professional fees in Corporate and Other relating to the Combination and the sale of GSUSA, and a $1.5 million loss on assets held for sale in our APUS Segment, both on a pre-tax basis. Costs and expenses for the six months ended June 30, 2024, included a $3.7 million loss on leases in our RU Segment, $2.0 million in information technology transition service costs in our APUS and HCN Segments as well as Corporate and Other, and $0.5 million in severance costs related to the former president of GSUSA in Corporate and Other and the planned campus closures of our campuses located in Wisconsin in our RU Segment, all on a pre-tax basis. Costs and expenses for the six months ended June 30, 2025, as compared to the prior year period, excluding the items noted above, increased $10.2 million, due primarily to increases in employee compensation costs, classroom and course materials costs, professional fees and bad debt expense, partially offset by decreases in information technology costs and depreciation and amortization expenses. Costs and expenses as a percentage of revenue decreased to 94.1% for the six months ended June 30, 2025, from 97.6% for the six months ended June 30, 2024.
Instructional costs and services expenses. Our instructional costs and services expenses for the six months ended June 30, 2025, were $153.4 million, an increase of $4.7 million, or 3.2%, compared to $148.6 million for the six months ended June 30, 2024. The increase in instructional costs and services expenses were primarily due to increases in faculty compensation costs in our RU, APUS, and HCN Segments due to an increase in registrations at APUS and enrollments at RU and HCN and an increase in classroom and course materials costs in our RU and HCN Segments, partially offset by a decrease in information technology costs in our RU Segment, a decrease in occupancy costs in our RU and HCN Segments, and a decrease in employee compensation costs in Corporate and Other related to the decrease in revenue at GSUSA. Instructional costs and services expenses as a percentage of revenue decreased to 46.9% for the six months ended June 30, 2025, from 48.4% for the three months ended June 30, 2024.
Selling and promotional expenses. Our selling and promotional expenses for the six months ended June 30, 2025, were $70.3 million, an increase of $4.0 million, or 6.0%, compared to $66.3 million for the six months ended June 30, 2024. The increase in selling and promotional expenses were primarily due to increases in employee compensation costs in all of our segments, an increase in advertising costs in our APUS and HCN Segments, and marketing support costs in our RU Segment, partially offset by a decrease in advertising costs in our RU Segment. Selling and promotional expenses as a percentage of revenue decreased to 21.5% for the six months ended June 30, 2025, from 21.6% for the six months ended June 30, 2024.
General and administrative expenses. Our general and administrative expenses for the six months ended June 30, 2025, were $74.6 million, an increase of $3.9 million, or 5.4%, compared to $70.7 million for the six months ended June 30, 2024. General and administrative expenses for the six months ended June 30, 2025, included $2.7 million in pre-tax professional fees relating to the Combination in Corporate and Other and the sale of GSUSA. General and administrative expenses for the six months ended June 30, 2024, included $2.0 million in information technology transition service costs in our APUS and HCN Segments as well as Corporate and Other, and $0.5 million in severance costs related to the former president of GSUSA in Corporate and Other and the planned campus closures of our campuses located in Wisconsin in our RU Segment, both on a pre-tax basis. The increase in general and administrative expenses was primarily due to increases in employee compensation costs and professional fees in Corporate and Other, and bad debt expense in all of our segments, partially offset by a decrease in
34
information technology costs and employee compensation costs in our APUS and RU Segments. Consolidated bad debt expense for the six months ended June 30, 2025, was $9.8 million, or 3.0% of revenue, compared to $8.5 million, or 2.8% of revenue in the prior year period. General and administrative expenses as a percentage of revenue decreased to 22.8% for the six months ended June 30, 2025, from 23.0% for the six months ended June 30, 2024. As we continue to evaluate enhancements to our business capabilities, we may incur additional costs and that our general and administrative expenses will vary from time to time.
Depreciation and amortization expenses. Depreciation and amortization expenses were $8.1 million for six months ended June 30, 2025, compared to $10.4 million in the prior year period, a decrease of $2.3 million primarily related to the full amortization of all definite lived intangible assets in our RU Segment in 2024. Depreciation and amortization expenses as a percentage of revenue was 2.5% and 3.4% for the six months ended June 30, 2025, and 2024, respectively.
Loss on assets held for sale. For the six months ended June 30, 2025, the $1.5 million pre-tax non-cash loss on assets held for sale is for real property located in Charles Town, West Virginia in our APUS Segment. There was no loss on assets held for sale in the prior year.
Loss on leases. RU Segment loss on leases was $3.7 million for the six months ended June 30, 2024. There was no loss on leases in the current year period.
Loss on disposals of long-lived assets. The loss on disposal of long-lived assets was $0.3 million for the six months ended June 30, 2025, compared to a loss of $0.2 million for the six months ended June 30, 2024.
Stock-based compensation expenses. Stock-based compensation expenses included in instructional costs and services, selling and promotional, and general and administrative expenses were $4.5 million and $3.7 million for the six months ended June 30, 2025, and 2024, respectively. Stock-based compensation costs included accelerated expense for retirement-eligible employees and performance stock unit incentive costs.
Interest expense, net. Interest expense, net of interest and other income, was $2.0 million and $0.9 million for the six months ended June 30, 2025, and 2024, respectively. The increase in net interest expense was primarily due to an increase in interest expense due to the expiration of the interest rate cap in December 2024, and a decrease in interest income earned, as compared to the prior year period.
Income tax expense. We recognized income tax expense of $3.9 million and $1.2 million for the six months ended June 30, 2025, and 2024, respectively, or an effective tax rate of 22.5% and 57.4%, respectively. The effective tax rate in 2025 was positively impacted by excess tax benefits related to stock compensation. The effective tax rate in 2024 is primarily due to the $4.4 million equity investment loss not deductible for tax purposes, and an increase in non-deductible stock compensation expense in relation to taxable income in the period.
Equity investment loss. There was no equity investment loss for the six months ended June 30, 2025. The equity investment loss of $4.4 million for six months ended June 30, 2024 was related to a $3.3 million non-cash investment loss on an equity investment due to the investee entering into a new convertible debt agreements, which resulted in the conversion of our preferred stock holdings in the investee into common shares, and the dilution of our ownership percentage, and a $1.1 million loss on sale of our remaining equity method investment.
Net income. Our net income was $13.4 million and $0.9 million, for the six months ended June 30, 2025, and 2024, respectively, an increase of $12.5 million. This increase was related to the factors discussed above.
Preferred stock dividends. Preferred stock dividends were $2.8 million and $3.1 million, for the six months ended June 30, 2025, and 2024, respectively.
Loss on redemption of preferred stock. In June 2025, we redeemed all of our outstanding Series A Senior Preferred Stock for $43.1 million, excluding unpaid and accrued dividends of $1.4 million, resulting in a loss of $3.5 million related to the redemption premium and fees.
Net income (loss) available to common stockholders. The net income available to common stockholders was $7.1 million, for the six months ended June 30, 2025, compared to a net loss available to common stockholders of $2.2 million for the six months ended June 30, 2024, an improvement of $9.3 million. This improvement was related to the factors discussed above.
35
Analysis of Operating Results by Reportable Segment
The following table provides details on our operating results by reportable segment for the respective periods (in thousands):
| Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Unaudited) | (Unaudited) | ||||||||||||||||||||||
| Revenue: | |||||||||||||||||||||||
| APUS Segment | $ | 81,731 | $ | 77,048 | $ | 165,677 | $ | 157,704 | |||||||||||||||
| RU Segment | 59,521 | 53,034 | 118,772 | 106,169 | |||||||||||||||||||
| HCN Segment | 18,134 | 16,409 | 35,810 | 32,856 | |||||||||||||||||||
| Corporate and Other | 3,380 | 6,404 | 7,058 | 10,598 | |||||||||||||||||||
| Total revenue | $ | 162,766 | $ | 152,895 | $ | 327,317 | $ | 307,327 | |||||||||||||||
| Income (loss) from operations before interest and income taxes: | |||||||||||||||||||||||
| APUS Segment | $ | 21,442 | $ | 18,291 | $ | 45,568 | $ | 41,378 | |||||||||||||||
| RU Segment | (1,976) | (8,826) | (2,048) | (17,792) | |||||||||||||||||||
| HCN Segment | (402) | (744) | (1,148) | (1,048) | |||||||||||||||||||
| Corporate and Other | (12,039) | (6,501) | (23,101) | (15,136) | |||||||||||||||||||
| Total income from operations before interest and income taxes | $ | 7,025 | $ | 2,220 | $ | 19,271 | $ | 7,402 | |||||||||||||||
APUS Segment
For the three months ended June 30, 2025, the $4.7 million, or 6.1%, increase to approximately $81.7 million in revenue in our APUS Segment was primarily attributable to higher net course registrations, as compared to the prior year period. Net course registrations increased 7.3% to approximately 96,400 from approximately 89,800 in the prior year period, primarily due to an increase in registrations by students utilizing federal student aid and military-affiliated students utilizing VA. Income from operations before interest and income taxes increased to $21.4 million during the three months ended June 30, 2025, from $18.3 million in the prior year period, an increase of $3.2 million, or 17.2%, and was primarily due to an to the increase in revenue and a decrease in information technology costs, partially offset by an increase in employee compensation costs, as compared to the prior year period.
For the six months ended June 30, 2025, the $8.0 million, or 5.1%, increase to approximately $165.7 million in revenue in our APUS Segment was primarily attributable to higher net course registrations, as compared to the prior year period. Net course registrations increased 5.3% to approximately 198,900 from approximately 188,800 in the prior year period, primarily due to an increase in registrations by students utilizing federal student aid military-affiliated students utilizing VA. Income from operations before interest and income taxes increased to $45.6 million during the six months ended June 30, 2025 from $41.4 million in the prior year period, an increase of $4.2 million, or 10.1%, as a result of the increase in revenue and a decrease in professional fees, partially offset by increases in employee compensation costs and the loss on assets held for sale, as compared to the prior year period.
RU Segment
For the three months ended June 30, 2025, the $6.5 million, or 12.2%, increase to approximately $59.5 million in revenue in the RU Segment was primarily due to a 7.4% increase in total student enrollment which was driven by a 12.2% increase in online enrollment and a 3.2% increase in on-ground enrollment, as compared to the prior year period, and the impact of tuition increases in 2024. The loss from operations before interest and income taxes was $2.0 million and $8.8 million for the three months ended June 30, 2025, and 2024, respectively, an improvement of $6.9 million primarily due to the increase in revenue as well as decreases in information technology costs, depreciation and amortization expenses, and loss on leases, partially offset by an increase in employee compensation costs, as compared to the prior year period.
For the six months ended June 30, 2025, the $12.6 million, or 11.9%, increase to approximately $118.8 million in revenue in the RU Segment was primarily due to a 7.4% increase in total student enrollment which was driven by a 11.6% increase in online enrollment and a 3.2% increase in on-ground enrollment, as compared to the prior year period, and the impact of tuition increases in 2024. The loss from operations before interest and income taxes was $2.0 million and $17.8 million for
36
the six months ended June 30, 2025, and 2024, respectively, an improvement of $15.7 million primarily due to the increase in revenue as well as decreases in loss on leases, information technology costs, and depreciation and amortization expenses, partially offset by an increase in employee compensation costs, classroom and course materials costs, and bad debt expense, as compared to the prior year period.
HCN Segment
For the three months ended June 30, 2025, the $1.7 million, or 10.5%, increase to approximately $18.1 million in revenue in our HCN Segment was primarily due to a 13.5% increase in total student enrollment, as compared to the prior year period. The loss from operations before interest and income taxes was $0.4 million and $0.7 million during the three months ended June 30, 2025, and 2024, respectively, an improvement of $0.3 million, primarily due to the increase in revenue, partially offset by increases in employee compensation costs, classroom and course materials costs, and bad debt expense, as compared to the prior year period.
For the six months ended June 30, 2025, the $3.0 million, or 9.0%, increase to approximately $35.8 million in revenue in our HCN Segment was primarily due to a 11.5% increase in total student enrollment, as compared to the prior year period. The loss from operations before interest and income taxes was $1.1 million and $1.0 million during the six months ended June 30, 2025, and 2024, respectively, a decline of $0.1 million, primarily due to an increase in employee compensation costs, bad debt expense, and classroom and course materials costs partially offset by the increase in revenue and decrease in professional fees.
Liquidity and Capital Resources
Liquidity
Cash and cash equivalents were $176.6 million and $158.9 million at June 30, 2025, and December 31, 2024, respectively, representing an increase of $17.6 million, or 11.1%. The increase in cash was primarily due to the collection of TA accounts receivable at APUS, the proceeds from the sale of assets held for sale, and the improved financial performance at RU, partially offset by the redemption of our Series A Senior Preferred Stock. We have historically financed operating activities and capital expenditures with cash provided by operating activities. We expect to continue to fund our costs and expenses through cash generated from operations for the next twelve months and beyond. For more on our material cash requirements from known contractual and other obligations, please refer to the section entitled “Contractual Obligations” in Item 7 of Part II of our Annual Report.
We derive a significant portion of our revenue from our participation in ED’s Title IV programs, for which disbursements are governed by federal regulations. We have typically received disbursements under Title IV programs within 30 days of the start of the applicable course or term. Another significant source of revenue is derived from TA from DoD and programs from VA. Generally, these funds are received within 60 days of the start of the courses to which they relate. However, in September 2023, APUS changed its approach to invoicing for TA, taking longer to bill TA, which had the effect of delaying payments from 2023 to 2024. Due to this change in the approach to invoicing TA in the fourth quarter of 2023, APUS collected approximately $22.1 million from TA related to periods prior to 2024. In January 2024, APUS separately revised its billing policy for students utilizing TA from two weeks to five weeks after course start date to nine weeks after the course start date. In December 2024, APUS again changed its approach to invoicing for TA, taking longer to bill TA, which had the effect of delaying payments from 2024 to 2025. As a result, during the six months ended June 30, 2025, due to this change in the approach to invoicing TA in the fourth quarter of 2024, APUS collected approximately $32.5 million from TA related to periods prior to 2025.
While the change in billing approach positively impacted the “90%” side of the ratio in 2024 under the 90/10 Rule, it reduced operating cash flow in 2024, increased operating cash flow in 2025, may result in increased bad debt expense in 2025, and may cause the “90%” side of the ratio to increase in 2025 or future years, which could have an adverse impact on our cash flow and results of operations, as well as APUS’s ability to comply with the 90/10 Rule in 2025 or future years. In order to comply in 2025 or future years, we may implement similar changes in our billing approach. The change in billing practice added to our accounts receivable as of December 31, 2024, and resulted in an increase to our leverage ratios as of December 31, 2024, under our Credit Agreement and the purchase agreement for the shares of Series A Senior Preferred Stock as further discussed in “Note 8. Long-Term Debt” and “Note 12. Preferred Stock” included in the Consolidated Financial Statements in this Quarterly Report.
ED evaluates institutions on an annual basis for compliance with specified financial responsibility standards, including a composite score calculation based on a complex formula using line items from the institution’s audited financial statements.
37
Generally, an institution’s composite score must be at least 1.5 for the institution to be deemed financially responsible. A composite score between 1.0 and 1.5 is considered by ED to be in the “zone.” An institution in the “zone” may still participate in Title IV programs as a financially responsible institution through the “zone alternative” as set forth in ED regulations. On April 9, 2025, ED notified us that according to its calculations, we had a fiscal year end 2023 consolidated composite score of 1.3 and our institutions were therefore in the “zone.” On April 13, 2025, we timely informed ED that we selected the “zone alternative” as the alternative basis on which we establish financial responsibility. As a result, APUS, RU and HCN currently operate under the zone alternative to establish financial responsibility. Under the zone alternative, we are required to: (i) make Title IV disbursements to eligible students and parents under the heightened cash monitoring payment method, or HCM1, pursuant to which we would be required to first make disbursements to eligible students and parents and pay any credit balances before we request or receive funds from ED for the amount of those disbursements; (ii) notify ED of certain oversight and financial events; and (iii) require our auditors to express an opinion on our compliance with the requirements under the zone alternative. Our placement on HCM1 status did not have a significant impact on our financial results for the three and six months ended June 30, 2025, and 2024.
As of December 31, 2024, restricted cash included a $25.4 million restricted certificate of deposit to secure a letter of credit for the benefit of ED on behalf of RU in connection with RU’s 2020 composite score, which is used by ED for determining compliance with financial responsibility standards, being below the minimum required. In May 2025, the letter of credit was released by ED, and the related cash was thereby no longer restricted.
Our Credit Agreement contains financial covenants that require us to maintain a Total Net Leverage Ratio (as defined in each respective agreement) of no greater than 2.00 to 1.00 and 0.75 to 1.00, respectively, subject to certain exceptions. Our Total Net Leverage Ratio, under the Credit Agreement, at June 30, 2025, was negative 0.31 due to the growth in both cash and earnings, and the reduction in restricted cash. The net leverage ratio at December 31, 2024 was 0.20. While we do not anticipate that a higher leverage ratio will have material limitations on our expected operations for 2025, it could result in reduced operational flexibility in 2026 and future years.
Capital expenditures could be higher in the future as a result of, among other things, additional expenditures for technology or other business capabilities, the maintenance of existing campuses at RU and HCN, the opening of new campuses or the consolidation of existing campuses at RU and HCN, the acquisition or lease of existing structures or potential new construction projects, and necessary tenant improvements that arise as a result of our ongoing evaluation of our space needs and opportunities for physical growth. We also expect to continue to explore opportunities to invest in the education industry, which could include purchasing or investing in other education-related companies or companies developing new technologies.
On January 28, 2025, we announced the Combination. For the period ended June 30, 2025, we incurred approximately $2.4 million in professional fees related to the Combination, and we expect to incur between approximately an additional $1.0 million and $2.0 million in professional fees for the remainder of 2025 in connection with the Combination.
On June 23, 2025, APEI redeemed all 400 outstanding shares of Series A Senior Preferred Stock for $43.1 million, excluding unpaid and accrued dividends of $1.4 million. Accordingly, no shares of preferred stock were issued or outstanding at June 30, 2025. For additional details regarding the redemption of the Series A Senior Preferred Stock, please refer to “Note 12. Preferred Stock” included in our Consolidated Financial Statements.
Operating Activities
Net cash provided by operating activities was $51.8 million and $33.2 million for the six months ended June 30, 2025, and 2024, respectively. The increase in cash from operating activities was primarily due to the collection of TA accounts receivable at APUS related to the 2024 change in TA billing approach, the improved financial performance at RU, and other changes in working capital due to the timing of receipts and payments. Accounts receivable at June 30, 2025, decreased approximately $24.9 million compared to December 31, 2024, primarily related to TA collections in our APUS Segment. Accounts payable, accrued liabilities, and accrued compensation and benefits at June 30, 2025, were approximately $2.4 million higher than December 31, 2024.
Investing Activities
Net cash provided by investing activities was $15.4 million for the six months ended June 30, 2025, compared to $11.4 million of net cash used in investing activities for the six months ended June 30, 2024. For the six months ended June 30, 2025, cash provided by investing activities includes $23.0 million in proceeds from the sale of assets held for sale. Capital expenditures were $7.6 million and $11.4 million for the six months ended June 30, 2025, and 2024, respectively. Prior year period capital expenditures were higher than the current year period primarily due to campus consolidations at RU and relocations at HCN that occurred in the prior year period.
38
Financing Activities
Net cash used in financing activities was $49.5 million and $9.9 million for the six months ended June 30, 2025, and 2024, respectively. The increase in cash used in financial activities is due to our redemption of our Series A Senior Preferred Stock in June 2025 for $43.1 million, excluding unpaid and accrued dividends of $1.4 million.
Financing activities include preferred stock dividends paid of $2.8 million and $3.1 million for the six months ended June 30, 2025, and 2024, respectively. Financing activities for the six months ended June 30, 2024, include $2.8 million paid for the repurchase of 251,146 shares of common stock, and $2.6 million in principal payments on our long term debt.
Contractual Commitments
We have various contractual obligations consisting of operating leases and purchase obligations. Purchase obligations include agreements with consultants, contracts with third-party service providers, and other future contracts or agreements. For a summary of our contractual obligations, please refer to Item 7 of Part II of our Annual Report.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
Market Risk
We had no material derivative financial instruments or derivative commodity instruments as of June 30, 2025. We maintain our cash and cash equivalents in bank deposit accounts, money market funds, and short-term U.S. Treasury bills. The bank deposits exceed federally insured limits. We have historically not experienced any losses in such accounts. We believe we are not exposed to any significant credit risk on cash and cash equivalents. Due to the short-term duration of our investment portfolio, the low yield on the portfolio, and the low risk profile of our investments, a 10% increase or decrease in interest rates would not have a material impact on the fair value of our portfolio.
Interest Rate Risk
We are subject to risk from changes in interest rates primarily relating to our investment of funds in short-term U.S. Treasury bills issued at a discount to their par value. Our future investment income will vary due to changes in interest rates.
In the normal course of business, we employ established policies and procedures to manage our exposure to changes in interest rates. For every 100 basis points increase in Term SOFR, we would incur an incremental $1.0 million in interest expense per year, excluding any impact offset from the interest rate cap agreement. To reduce our exposure to market risks from increases in interest rates on our variable rate indebtedness we have entered into hedging arrangements in the form of interest rate cap agreements. As further discussed in “Note 8. Long-Term Debt” included in the Notes to the Consolidated Financial Statements in this Quarterly Report, prior to December 31, 2024, an interest rate cap agreement provided us with interest rate protection in the event the one-month Term SOFR rate increases above 1.78%. In January 2025, upon the expiration of the prior agreement, we entered into a new interest rate cap agreement with a notional value of $50.0 million, which provides us with interest rate protection in the event that the Term SOFR rate exceeds 5.00%. This interest rate cap agreement will expire in June 2026.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act) as of June 30, 2025. Based upon the evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2025.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
39
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
From time to time, we have been and may be involved in various legal proceedings. We currently have no material legal proceedings pending.
Item 1A. Risk Factors
An investment in our stock involves a high degree of risk. You should carefully consider the risks set forth in the “Risk Factors” section of our Annual Report and the other information set forth in this Quarterly Report on Form 10-Q, our Annual Report, and the additional information in the other reports we file with the SEC. If any of the risks contained in those reports actually occur, our business, results of operation, financial condition, and liquidity could be harmed, the value of our securities could decline, and you could lose all or part of your investment. With the exception of the following, there have been no material changes in the risk factors set forth in the “Risk Factors” section of our Annual Report.
There are risks associated with the Combination, including with respect to the anticipated timeline.
We previously disclosed that we had anticipated completing the Combination in the third quarter of 2025 subject to obtaining required approvals and ED taking related actions. At its June 2025 meeting, HLC approved the Combination and continuation of accreditation upon implementation of the related transactions. As a result of ongoing dialogue with ED and HLC as to their preferred implementation process for and the timing of the Combination, the implementation of the Combination may be postponed, including potentially into the second quarter of 2026.
For additional information regarding risks related to the Combination, see our Form 10-K and the Risk Factor in that Form 10-K with the caption beginning “The planned combination of APUS, RU, and HCN….”
The postsecondary education regulatory environment has changed and may change in the future as a result of U.S. federal elections.
Changes in Presidential administrations and control of Congress as a result of the outcome of elections or other events has in the past resulted and could in the future result in changes in or new legislation, appropriations, regulations, standards, policies and enforcement actions that could materially affect our business, including material consequences for our institutions’ accreditation, authorization to operate in various states, permissible activities, receipt of funds under student financial assistance programs, and cost of doing business. The Trump administration and current Congress may act to change or eliminate education-related legislation and ED regulations, to enact new legislation to alter existing regulations, and to change existing ED policies and practices with respect to matters related to postsecondary education institutions.
President Trump and members of his administration have also stated that the administration intends to dismantle ED, limiting its functions to only those that are statutorily required or transferring oversight of certain functions to other agencies. On March 11, 2025, ED announced a reduction in force, or RIF, effective March 21, 2025, resulting in office, staff, and program cuts. ED has claimed the reduction in force will not directly impact students and families and will empower states and localities. On May 22, 2025, a federal judge ordered ED to reverse the RIF, which order ED has appealed. On July 14, 2025, the order was stayed by the U.S. Supreme Court pending disposition of the appeal, thus allowing the RIF to proceed. Relatedly, on March 20, 2025, President Trump signed an Executive Order titled “Improving Education Outcomes by Empowering Parents, States, and Communities”, or the Executive Order, which, among other things, instructed the Secretary of Education to facilitate the closure of ED and maintain certain services, programs, and benefits, including student loans and Pell grants. We cannot predict the extent to which the RIF or the Executive Order will impact our results of operations and business, including as it relates to the Combination.
We cannot predict what additional actions the Trump administration will take with respect to the operations of ED or the response of the staff of ED to any such actions, nor can we predict the extent to which the Trump administration and Congress, or any future administration or Congress, will act to change or eliminate or to implement new laws, regulations, standards, policies, and practices, nor can we predict the form that new laws, regulations, standards, policies, or practices may take or the extent to which those regulations, practices or policies may impact us or our institutions or federal funds disbursed to schools through Title IV programs or TA, nor can we predict whether any challenges to actions taken by the Trump
40
administration will be successful. For example, even without changes being made to Title IV programs, more general changes or uncertainty at ED could cause disruptions or delays in the processing of Title IV or other necessary interactions with ED. Significant changes to ED or to federal regulation of higher education could have a material adverse impact on our enrollment, revenue, results of operations, and financial condition.
The OBBBA may adversely impact us or our students’ ability to participate in federal student financial aid programs, which could have a significant adverse impact on enrollments and our business, operations, and financial results.
As discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Overview – Legislative and Regulatory Activity– The One Big Beautiful Bill Act”, President Trump recently signed into law the OBBBA, which, among other things, makes significant changes to federal student financial aid programs and eligibility requirements for such programs. New caps on federal loans for graduate and professional students and parents of undergraduates may limit borrowing options for our students and the accountability framework and related earnings test may limit the availability of certain programs due to a potential loss of Federal Direct Loan eligibility. These changes may impact our students’ ability to participate in federal student loan programs, which may have a significant adverse impact on enrollments and our business, operations, and financial results. Various portions of the OBBBA may go through negotiated rulemaking prior to implementation, and we cannot predict the timing or outcome of those negotiations or the rulemaking process.
41
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Repurchases
The table and footnotes below provide details regarding our repurchase programs (unaudited):
| Total Number of Shares Purchased | Average Price Paid per Share | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (1) | Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (2) | ||||||||||||||||||||||||||||
| April 1, 2025 | — | — | — | 556,518 | 5,979,687 | |||||||||||||||||||||||||||
| April 1, 2025 - April 30, 2025 | — | — | — | 557,067 | 5,979,687 | |||||||||||||||||||||||||||
| May 1, 2025 - May 31, 2025 | — | — | — | 579,579 | 5,979,687 | |||||||||||||||||||||||||||
| June 1, 2025 - June 30, 2025 | — | — | — | 579,579 | 5,979,687 | |||||||||||||||||||||||||||
| Total | — | — | — | 579,579 | $ | 5,979,687 | ||||||||||||||||||||||||||
(1)On December 9, 2011, our Board of Directors, or Board, approved a stock repurchase program for our common stock, under which we could annually purchase up to the cumulative number of shares issued or deemed issued in each year under our equity incentive and stock purchase plans. Repurchases may be made from time to time in the open market at prevailing market prices or in privately negotiated transactions based on business and market conditions. The stock repurchase program does not obligate us to repurchase any shares, may be suspended or discontinued at any time, and is funded using our available cash.
(2)On May 2, 2019, our Board of Directors authorized the repurchase of up to $35.0 million of shares of our common stock, and on December 5, 2019, our Board approved an additional authorization of up to $25.0 million of shares. On November 27, 2023, our Board approved an additional authorization of up to $10.0 million of shares. We may purchase shares at management’s discretion in the open market, in privately negotiated transactions, in transactions structured through investment banking institutions, or a combination of the foregoing. We may from time to time enter into Rule 10b5-1 plans to facilitate repurchases of shares under this authorization. The amount and timing of repurchases are subject to a variety of factors, including liquidity, cash flow, stock price, and general business and market conditions. We have no obligation to repurchase shares and may modify, suspend, or discontinue the repurchase program at any time. The authorization under this program is in addition to our repurchase program under which we may annually purchase up to the cumulative number of shares issued or deemed issued in that year under our equity incentive and stock purchase plan.
(3)During the three months ended June 30, 2025, we were deemed to have repurchased 1,286 shares of common stock forfeited by employees to satisfy minimum tax-withholding requirements in connection with the vesting of restricted stock grants. These repurchases were not part of the stock repurchase program authorized by our Board as described in footnotes 1 and 2 of this table.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
None.
42
Item 5. Other Information
On August 4, 2025, the Board of Directors of the Company, or the Board, appointed James Kenigsberg as Interim Chief Innovation and Technology Officer of the Company and Mr. Kenigsberg resigned from the Board, including as Chair of the Nominating and Corporate Governance Committee of the Board and a member of the Management Development and Compensation Committee of the Board, in each case effective immediately. The Board reduced the size of the Board to six members effective as of that time.
On August 4, 2025, the Company and Craig MacGibbon determined that Mr. MacGibbon will step down from his role as Executive Vice President, Chief Information Officer, effective August 19, 2025. Mr. MacGibbon will receive severance benefits under the terms of the American Public Education, Inc. Executive Severance Plan consistent with the provisions for a termination of employment without cause. A copy of the Executive Severance Plan is filed as Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on May 15, 2017.
During the three months ended June 30, 2025, none of our directors or officers adopted terminated
| Name and Title | Date Adopted | Character of trading Agreement | Aggregate Number of Shares of Common Stock to be (Sold) Purchased Pursuant to Trading Agreement | Duration | ||||||||||
| Rule 10b5-1 Trading Arrangement | Up to ( | August 29, 2025 (2) | ||||||||||||
| Rule 10b5-1 Trading Arrangement | (4) | |||||||||||||
| (1) The figure presented represents shares to be sold upon the vesting of equity awards. | ||||||||||||||
| (2) This trading arrangement was terminated on June 11, 2025, but would have otherwise permitted transactions through and including the earlier to occur of (a) the completion of all sales on the respective order entry date and (b) the date listed in the table. | ||||||||||||||
| (3) This trading arrangement was entered into by 325 Capital LLC, a Delaware limited liability company (“325”). 325 serves as the investment manager of certain separately managed accounts (“SMAs”) and is deemed to beneficially own the shares directly held in the SMAs. Mr. Braner is a managing member of 325 and may be deemed to beneficially own the securities beneficially owned by 325. | ||||||||||||||
| (4) This trading arrangement provides for the sale of shares held by each of 325’s SMAs whose value, as calculated each trading day for the duration of the trading agreement, equals or exceeds 15% of the aggregate value of assets held by the respective SMA; however, the sale of such shares on any given day may not exceed 10% of the daily average trading volume for such day. | ||||||||||||||
43
Item 6. Exhibits
| Exhibit No. | Exhibit Description | ||||
| 3.1 | Fifth Amended and Restated Certificate of Incorporation of the Company (1) | ||||
| 3.2 | Certificate of Elimination of Series A Senior Preferred Stock of American Public Education, Inc. (2) | ||||
| 10.1 | Amendment Number Four to the American Public Education, Inc. 2017 Omnibus Incentive Plan (3) | ||||
| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (4) | ||||
| 31.2 | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) under the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (4) | ||||
| 32.1 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (5) | ||||
| EX-101.INS | Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | ||||
| EX-101.SCH | Inline XBRL Taxonomy Extension Schema Document | ||||
| EX-101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document | ||||
| EX-101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document | ||||
| EX-101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document | ||||
| EX-101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document | ||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | ||||
| (1) | Incorporated by reference to exhibit filed with Registrant’s Current Report on Form 8-K (File No. 001-33810), filed with the SEC on November 14, 2007. | ||||
| (2) | Incorporated by reference to exhibit filed with the Company’s Current Report on Form 8-K (File No. 001-33810) filed with the SEC on June 23, 2025. | ||||
| (3) | Incorporated by reference to exhibit filed with the Company’s Current Report on Form 8-K (File No. 001-33810) filed with the SEC on May 27, 2025. | ||||
| (4) | Filed herewith. | ||||
| (5) | Furnished herewith. | ||||
44
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| AMERICAN PUBLIC EDUCATION, INC. | ||||||||
| /s/ Angela Selden | August 6, 2025 | |||||||
| Angela Selden | ||||||||
| President and Chief Executive Officer | ||||||||
| (Principal Executive Officer) | ||||||||
| /s/ Richard W. Sunderland, Jr. | August 6, 2025 | |||||||
| Richard W. Sunderland, Jr. | ||||||||
| Executive Vice President and Chief Financial Officer | ||||||||
| (Principal Financial Officer and Principal Accounting Officer) | ||||||||
45
FAQ
How much revenue did APEI (APEI) report for Q2 2025?
APEI generated $162.8 million in revenue for the quarter ended 30 Jun 25, up 6.5% year over year.
Did APEI earn a profit in the second quarter of 2025?
Yes. Net income was $4.5 million; however, after preferred dividends and redemption cost, the quarter showed a $0.3 million loss attributable to common shareholders.
What is APEI’s current cash position and debt level?
As of 30 Jun 25, cash and equivalents were $176.6 million; long-term term-loan debt remained $96.4 million maturing in 2027.
How did segment performance vary in Q2 2025 for APEI?
APUS earned $21.4 m operating income, while Rasmussen University and Hondros College posted operating losses of $2.0 m and $0.4 m, respectively.
What was the impact of the preferred stock redemption?
APEI paid $43.1 m to redeem all preferred shares, recorded a $3.5 m loss, and will avoid future dividends of roughly $2.7 m per half-year.
Has the sale of Graduate School USA been completed?
Yes. The company closed the divestiture of GSUSA on 25 Jul 25, after the quarter-end, allowing greater strategic focus on core degree programs.
American Public
NASDAQ:APEI
APEI Rankings
APEI Latest News
APEI Latest SEC Filings
APEI Stock Data
550.57M
17.19M
4.73%
96.79%
6.6%
Education & Training Services
Services-educational Services
United States
CHARLES TOWN